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ABSTRACT
CHARACTERIZATION OF MURINE INTERLEUKIN-4 (IL-4) BIOLOGICAL
ACTIVITIES AND INITIAL IDENTIFICATION OF SIGNAL TRANSDUCTION
MECHANISMS IN IL-4-MEDIATED MACROPHAGE ACTIVATION

by
Henkie Pierre Tan

IL-4, in the presence of macrophages (Mc1>s), has previously been
demonstrated to be tumoricidal in vitro and in vivo, possibly through Mcj>
activation.

In the current study, the biological activities of murine IL-4

on Mfs, and the initial identification of signal transduction mechanisms in
IL-4-mediated Mcj> activation were determined.

Hamster Mcj>s were

activated with IL-4 to study Mcj> tumoricidal activity against hamster
pancreatic adenocarcinoma in vivo.

Through this initial study, it was

observed that murine IL-4 is species specific and incapable of crossing the
narrow phylogenetic barrier to hamster and perhaps rat (partially).

The

effects of murine IL-4 on allogeneic peritoneal and bone marrow-derived
(14M1.4 cell line) Mcj>s were then evaluated.

Results showed a marked,

dose-dependent stimulation of chemiluminescent oxidative burst by IL-4activated Mfs, an activity which was IL-4 monoclonal antibody reversible.
In addition, it appeared that 14M1 .4 Mcj>s were more responsive than
peritoneal Mc1>s to IL-4 in that they responded quicker and released greater
quantities of reactive oxygen intermediates.

Based on this preliminary

work, the 14M1 .4 Mcj>s were used to study the yet unknown signal

transduction mechanisms in IL-4-mediated M. activation. By means of
flow cytometric techniques and the membrane potential sensitive dye,
DIOC6(3), it was shown that IL-4 caused no apparent biological but a
statistically significant change in the membrane potential of Ms. Using
flow cytometry and indo-1AM, it was determined that intracellular
calcium levels changed. An optimal concentration of 1L-4 caused a rapid
increase in the initial (inhibited by BAPTA-AM, a specific intracellular
chelator of calcium) and then sustained (inhibited by EGTA) level of
intracellular calcium. Through assessments of chemiluminescence
oxidative burst activity, it was demonstrated that the initial and
sustained increase in intracellular calcium was required and important for
IL-4 enhancement of the oxidative burst by 14M1.4 Ms. Increase in
production of 1P3 but no change in levels of cAMP, immediate or delayed,
were demonstrated using competitive binding assays. These findings were
further supported by the fact that cholera toxin and prostaglandin E2
(agents which increase cAMP), did not enhance chemiluminescence, nor did
PMA, a potent activator of PKC. Surprisingly, IL-4-stimulated McPs were
not cytolytic to tumor cell targets; yet, IL-4 was directly cytostatic to
some of the same cell lines.
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CHAPTER 1

INTRODUCTION
1.1. Structure and biochemical characteristics of IL-4 and
IL -4 receptor
1.1.1. IL-4
IL-4, a cytokine, was originally described as a ,murine B cell growth
factor (Howard et al., 1982) in the laboratory of William E. Paul at the
National Institute of Allergy and Infectious Disease. The structure and
biochemical characteristics of 1L-4 have been reviewed (Ohara, 1989;
Moller, 1989; Spits, 1992). Briefly, murine IL-4 complementary (c)DNA
was first isolated from a mouse Th2 cell library as a cDNA coding for a
unique mouse interleukin that expresses B cell-, T-cell-, and mast cellstimulating activities (Lee et al., 1986; Noma et al., 1986; Mosmann et al.,
1986a, b). Subsequently, a human 1L-4 cDNA was isolated by crosshybridization from an activated human T cell clone cDNA library (Yokota et
al., 1986). Both murine and human IL-4 genes occur as a single copy per
haploid genome and are mapped on chromosomes 11 and 5, respectively
(Otsuka et al., 1987; Arai et al., 1989). The IL-4 genes reside as part of a
cluster of lymphokine genes that includes IL-3, granulocyte macrophage
colony-stimulating factor (GM-CSF), and IL-5 (LeBeau et al., 1989;
VanLeeuwen et al., 1989). This region is known to be deleted (del[5q])
frequently in patients with myeloid disorders. Like other lymphokine
genes, such as IL-2, GM-CSF, interferon (IFN)--y, and IL-5 genes, the IL-4
genes are composed of four exons and three introns (Otsuka et al., 1987;
Arai et al., 1989). The mature polypeptides of murine and human IL-4 are
1
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120 and 129 amino acid residues long, respectively, and both begin with a
histidine residue. The predicted molecular weight of the nonglycosylated
murine and human IL-4 proteins are 13,558 and 14,963, respectively
(Trotta, 1992). The murine and human IL-4 proteins share about 50%
homology. Amino acid positions 91 to 128 of human IL-4, share very little
homology with the corresponding region of murine IL-4 at either amino
acid or nucleotide sequence levels (Yokota et al., 1988; Arai and Arai,
1992). There are no predicted sites for phosphorylation in either murine
or human IL-4, based on the sequence Arg-Arg-Ala-Ser-Leu, the
recognition sequence for cyclic adenosine monophosphate (cAMP)dependent protein kinase (Trotta, 1992). Murine and human IL-4 have
alkaline isoelectric points of 9.7 and 10.5, respectively.
The secondary structure of murine and human IL-4 has been predicted
to be significantly a-helical (64%) (Trotta, 1992). Human recombinant
(r)IL-4 appears to have a highly stable tertiary structure which has been
demonstrated to be stable to extreme pH (Windsor et al., 1991). In
addition, human a-4 has recently been crystallized (Cook et al., 1991).
Elucidation of the tertiary structure will constitute the first major step
toward identifying the receptor-binding domain, and will provide the basis
for the design of second-generation agonists and antagonists of human
IL-4 with therapeutic potential.
1.1.2. IL-4 receptor
Interest in the IL-4 receptor (R) is reflected by the intense rate of
publications, including Ohara, 1989; Banchereau and Galizzi, 1990;
Maliszewski and Fanslow, 1990; Maliszewski et al., 1990; Jacobs et al.,
1991; Garrone et al., 1991; Fernandez-Botran, 1991; Fanslow et al., 1991;
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Miyajima et al., 1992; Harada et al., 1992; and Tan et al., 1992a. Only a
single class of the high affinity IL-4R has been isolated. It has a Kd of
20-80 pM and is expressed on a wide variety of cells including
nonhemopoietic cells such as fibroblasts, neuroblasts, keratinocytes,
hepatocytes, and stromal cells (Lowenthal et al., 1988). The IL-4R on
resting B cells is upregulated by lipopolysaccharide (LPS), anti-IgM, or
IL-4 itself, and the IL-4R on resting T cells is likewise increased by
stimulation with concanavalin (con) A or IL-4 (Lowenthal et al., 1988;
Ohara and Paul, 1987). Chemical cross-linking revealed multiple crosslinked proteins of 140-, and 50- to 75-kDa (Ohara and Paul, 1987; Park et
al., 1987). The smaller proteins appear to be degradation products of the
140-kDa protein. Gibbon IL-4R was purified by human IL-4 affinity
chromatography. Purified gibbon IL-4R of 130-kDa bound IL-4 with a Kd of
35 pM (Galizzi et al., 1990a), indicating that a single molecular species
binds IL-4 with high affinity. IL-4R cDNAs cloned from T cells, mast
cells, and myeloid cells encode a protein of 140-kDa which binds IL-4 with
high affinity when expressed in COS cells (monkey kidney cell line) (Mosley
et al., 1989; Galizzi et al., 1990b; Harada et al., 1990; ldzerda et al., 1990).
The mouse and human 1L-4R, like the lymphokine, are about 50% identical
at the amino acid level, and contain the common motif of cytokine
receptors (Idzerda et al., 1990; Galizzi et al., 1990b; Harada et al., 1992).
A mouse cDNA encoding a soluble extracellular domain of the IL-4R has
been isolated, and shown to be capable of binding IL-4 with high affinity
(Mosley et al., 1989). There is no consensus sequence for any known
enzymes in the large cytoplasmic domains of 553 (mouse) and 569 (human)
amino acid residues, but there are many prolines and serines in the
cytoplasmic domains which could potentially be sites of phosphorylation.
The human IL-4R molecules expressed in CTLL, a mouse T cell line, and

4
BaF3, a proB cell line, are capable of transmitting growth signals in
response to human IL-4 (Idzerda et at., 1990; Harada et al., 1992).
1.2. Known biological activities of IL-4
The biological activities of IL-4 have been reviewed (Paul, 1987;
Paul and Ohara, 1987; Moller, 1989; Spits, 1992). 1L-4 was originally
described as a murine B cell growth factor (Howard et at., 1982) and has
subsequently been shown to have pleiotropic effects on multiple
hematological and nonhematological cellular lineages (Monroe et al., 1988;
Moller, 1989; Ohara, 1989; Banchereau et al., 1991; Tan et al., 1990,
1991a-d, 1992a, b). The host of functions ascribed to murine IL-4, on the
basis of in vitro studies, includes stimulation (in conjunction with antigen
or anti-IgM antibody) of, B cell proliferation (Howard et al., 1982), T cell
proliferation (Mosmann et at., 1986b), mast cell proliferation in
conjunction with IL-3 (Mosmann et al., 1986b), stimulation of
hematopoietic precursors of multiple lineages (Peschel et at., 1987;
Rennick et al., 1989a, b), fibroblast proliferation (Monroe et al., 1988),
macrophage (M4)) activation (Crawford et al., 1987; Tan et at., 1990,
1991a, d, 1992b), and polymorphonuclear leukocyte (PMN) activation (Boey
et al., 1989). IL-4 has also been shown to heighten the expression of class
1 (Stuart et at., 1988) and class 11 MHC antigens on Ms (Crawford et al.,
1987; Stuart et at., 1988), and class II MHC antigens on B cells (NoeIle et
at., 1984; Roehm et at., 1984), and to promote class switching for the
production of IgE and IgG1 (Snapper and Paul, 1987; Lutzker et at., 1988;
Tan et at., 1992a). Hart et al. (1989, 1991) and Gautam et al. (1992) have
suggested that IL-4 may be a powerful, previously unrecognized, antiinflammatory agent.
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Of greatest potential relevance to the use of IL-4 in clinical trials
are the findings related to activation of T cells, LAK cells, and M4)s. In
this regard, IL-4 is a T cell growth factor stimulating the proliferation of
antigen- and mitogen-stimulated T cells of both T helper and cytotoxic
function, often working synergistically with IL-2 (Widmer et al., 1987). It
appears to enhance the proliferation of resting thymocytes and peripheral
blood T cells, maintains their viability, and induces the proliferation of
activated T cells including lines and clones derived from tumor
infiltrating lymphocytes (Kawakami et al., 1988; Spits et al., 1988). It
also reduces the nonspecific cytolytic activity induced by 1L-2 from
peripheral blood lymphocytes and tumor (Kawakami et al., 1988, 1989).
The ability of IL-4 to induce proliferation of activated T cells and to
synergize with IL-2 in T cell growth is of potential importance in its
clinical application.
1.3. Potential anti-tumor properties of 1L-4
Interest in the potential anti-tumor properties of interleukin (1L)-4
stemmed from in vitro studies that had demonstrated the ability of murine
IL-4 to activate Mt:Ps (Crawford et al., 1987), lymphokine-activated killer
(LAK) cells (Mule et al., 1987) and cytolytic lymphocytes (Widmer and
Grabstein, 1987) to kill tumor cells. Very recently, it was shown that
IL-4 inhibits in vitro cell growth of human melanomas and carcinomas of
lung, gastric, breast or renal cell origins (Hoon et al., 1991, 1992).
Additionally, the tumoricidal activity of IL-4 has been confirmed in vivo
(Tepper et al., 1989; Bosco et al., 1990; Golumbek et al., 1991; Redmond et
al., 1992). Tepper et al. (1989), while working in the laboratory of Philip
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Lederl, developed transfected murine IL-4 gene cell lines that
spontaneously produce IL-4; when these cell lines were injected with
transplantable tumors, the production of IL-4 by the IL-4 transfected cell
lines correlated with the growth inhibition of tumor in Balb/c, athymic
nu/nu (deficient T cell), and beige (bg/bg, deficient natural killer (NK) and
cytotoxic T cell) mice. These investigators, in order to confirm that the
production of IL-4 was indeed directly involved in tumor growth
inhibition, injected anti-IL-4 monoclonal antibody (mAb) into tumorburdened mice and found a reversal of tumor growth inhibition. However,
more convincing data could have been presented had these authors
measured the serum levels of 1L-4 and correlated them to tumor growth
inhibition. Tepper et al. (1989) also provided data indicating that IL-4
could cause the regression of established tumors. In addition, they found
many 1%0s and eosinophils at the site of tumor inhibition suggesting that
the tumoricidal activity of IL-4 may be associated with the activation and
effector function of these Ms and eosinophils. Finally, recent clinical
trials using IL-4 and IL-2 combination therapy in patients with melanoma,
breast or renal cancer, have shown partial and complete tumor regressions
(Wong et al., 1992; Lotze, 1992a, b).
1.4. Possible mechanisms of IL-4-mediated tumoricidal
activities
The current speculated mechanisms of IL-4-mediated tumoricidal
activities are numerable. Given the results of in vitro studies, the (a)
generation of cytotoxic T lymphocytes or (b) activation of LAK and (c) NK
cells by IL-4, could be considered possible mechanisms in vivo.

However,

1 This data was presented in the American Association of Immunologists plenary lecture at the

Federation of American Society of Experimental Biology meeting, 1991.
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Tepper et al. (1989) have shown that the anti-tumor effect of IL-4 in vivo
for several tumor types is operational in the athymic (nu/nu) host,
suggesting that a primary role for cytotoxic T lymphocytes is unlikely.
Peace et al. (1988) found that murine rIL-4 could generate both T
cell-like and NK-like LAK cells. However, a 500-fold (2 ng/ml) higher
concentration of IL-4 was required compared to that needed to induce
class II MHC antigen expression of B cells. On the contrary, several
investigators have found that human rIL-4 not only suppressed IL-2induced LAK activity but strongly inhibited the induction and function of
LAK in tumor cell killing (Widmer et al., 1987; Spits et al., 1988; Gallagher
et al., 1988; Gerosa et al., 1988; Keever et al., 1989), thus pointing to the
existence of variability among the immune cells of different species in
response to the species specific IL-4.
While a mechanism involving NK cells remains a theoretical
possibility, the absence of lymphoid cells in the inflammatory lesions at
the tumor rejection site in Tepper's (1989) studies argues against such a
hypothesis. In addition, his preliminary studies indicate that the
anti-tumor effect of murine IL-4 is still operational in the beige (bg/bg)
mouse, which is deficient in NK activity (Roder and Duwe, 1979) and
cytotoxic T cell functions (Saxena et al., 1982). These data are further
supported by findings which indicate that human 1L-4 inhibits the
augmentation of NK cell activity by IL-2 (Spits et al., 1988; Keever et al.,
1989), and the generation of NK cells (Migliorati et al., 1989).
Finally, the appearance of a striking number of eosinophils, as well
as activated Mctis, at the tumor site in vivo suggests that mechanisms
independent of the lymphoid system may be operative. The presence of
activated McPs at the site of IL-4 production raises the possibility that
tumoricidal products are derived directly or indirectly from the M.
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Among the mediators released by McPs are the reactive oxygen
intermediates (02-, H202, HO', and 1 02), which have been correlated with
enhanced ability of Ms to kill bacteria (Gabay, 1988), parasites (Wirth et
al., 1989), and tumor cells (Wiltrout and •Varesio, 1990). Other tumoricidal
secretory products include IL-1 (Onozaki et al., 1985a, b; Lovett et al.,
1986), tumor necrosis factor (TNF)-a (Urban et al., 1986), and macrophage
colony-stimulating factor (MCSF) which, in turn, could activate Mci) to
produce tumoricidal products such as interferon-a, TNF-a, and GM-CSF
(Warren and Ralph, 1986; Grabstein et al.; 1986a; Ralph and Nakoinz, 1987;
Wieser et al., 1989). Although it has been claimed that murine IL-4
enhances the production of IL-1 (Wolpe et al., 1987) and TNF (Somers and
Erickson, 1988), others (Hurme et al., 1988; Hart et al., 1989, 1991; Essner
et al., 1989) have reported that species-specific human IL-4 inhibits IL-1
and TNF synthesis in monocytes and macrophages. While Crawford et al.
(1987) have shown that IL-4 increases the Fc receptor expression of bone
marrow-derived Ms, Ralph et al. (1988) found that rIL-4 did not stimulate
antibody-dependent cellular cytotoxicity by peritoneal M(Ps. However, Fan
et al. (1991) were able to strongly stimulate both rapid and slow antibodydependent cellular cytotoxicity. These differences may be attributable to
differences in target susceptibility. The tumoricidal activity of IL-4activated Ms through a non-specific mechanism 'remains a possibility
(Alexander, 1973; Kurland et al., 1979).
The role of eosinophils in the IL-4-mediated anti-tumor effect also
remains to be defined. Eosinophils are known to possess antibodydependent and -independent phagocytic properties and play an important
role in controlling certain parasitic infections (Weller and Goetzl, 1979),
and their possible role as anti-tumor effectors has been suggested (Jong
and Klebanoff, 1980). The presence of eosinophils in histologic sections of
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human gastric and colonic malignancies has been associated with an
improved prognosis (Iwasaki et al., 1986, Pretlow et al., 1983). In their
review, Gleich and Adolphson (1986) have stated that eosinophils produce
tumoricidal proteins and enzymes which include major basic proteins
(Butterworth et al., 1979) and endoperoxidase enzymes. Nathan and
Klebanoff (1982) have provided evidence that endoperoxidase enzymes act
synergistically with H202, generated by Ms, in destroying tumor cells. It
is currently unknown whether the promotion of eosinophil chemotaxis in
vivo is mediated directly by IL-4 or involves the secondary expression of
other factors known to stimulate eosinophils, such as the eosinophil
chemotactic factor A released by activated mast cells (Gleich and
Adolphson, 1986), platelet aggregating factor (Braquet and RolaPleszczynski 1987), and eosinophil differentiation factor or IL-5
(Sanderson et al., 1986). While IL-4 in conjunction with IL-3 is known to
stimulate mast cells in vitro (Arai et al., 1990), no increase in tissue
mast cells was observed in Giemsa-stained tissue sections studied after
administration of IL-4 in vivo (Tepper et al., 1989)...
1.5. Significance of macrophage activation
The importance of the

no

in the immune system can not be over

emphasized, as indicated by a recent review entiqed "Lymphocytes Play
the Music but the Mc Calls the Tune" (Solbach et. al., 1991). Animals will
not survive in the absence of an intact mononuclear phagocytic system
while they will if their lymphoid system is not completely functional
(Esgro et al., 1990). The M4) plays many roles including an active role in
the immunosurveillance of cancer. The tumor cell killing by M4)s, which
avoids damaging normal tissue, is apparently not associated with the
development of tumor-specific resistance. The tumoricidal activity
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appears to be independent of target cell characteristics such as
immunogenicity, metastatic potential, and sensitivity to drugs (Esgro et
al., 1990, Whitworth et al., 1990, Pak and Fidler, 1991). However, the
destruction of tumor cells is, in part, due to the MI) secretory repertoire
(Adams et al., 1981; Nathan, 1982; Johnson et al., 1986; Lefkowitz et al.,
1986; Hamilton and Adams, 1987; Adams and Hamilton, 1988a). Among the
important mediators released by Ms are the reactive oxygen
intermediates, which have been correlated with an enhanced ability to kill
bacteria (Gabay, 1988), parasites (Wirth et al., 1989), and tumor cells
(Wiltrout and Varesio, 1990). The release of these highly reactive oxygen
metabolites is enhanced by the M4) activation factor IL-4 (Phillips et al.,
1990; Redmond et al., 1990; Tan et al., 1990, 1991a, d). The importance of
the reactive oxygen intermediates is further demonstrated in patients
with chronic granulomatous disease where patients with this disease
suffer various chronic inflammatory conditions and infections due to
opportunistic and pathogenic microorganisms because their phagocytes
fail to produce reactive oxygen intermediates (Curnette, 1992).
There are four well-characterized means of assessing M4) activation
that do not involve cellular interactions between Ms and live target cells
(Stein et al., 1991):

1) respiratory burst activity with

chemiluminescence2; 2) MHC class ll antigen expression; 3) mannosyl
fucosyl receptor expression; and 4) M4) cytokine release after activation
with M4) activation factors. The choice of assay depends on the need to
discriminate between 1) resident and elicited, 2) resident and
immunologically active, or 3) elicited and activated M4)s.

2 Analysis of the individual reactive oxygen intermediates can also be tested. For example,
superoxide anion can be measured by the reduction of cytochrome C and hydrogen peroxide by
the dichlorofluorescin diacetate assay using flow cytometry (Robinson, 1990).
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1.6. Macrophage activation by respiratory oxidative burst
When McPs and other professional phagocytic cells (monocytes, PMNs
and eosinophils) are appropriately stimulated by opsonized
microorganisms, antigen-antibody complexes, chemotactic factors or
other stimuli, a reduced nicotinamide-adenine dinucleotide phosphate
(NADPH) oxidase-dependent respiratory oxidative burst is activated
resulting in the release of reactive oxygen intermediates (Abo et al., 1991;
Cross, 1992). These intermediates include superoxide anion (01),
hydrogen peroxide (H202), and hydroxyl radicals (OH). At the outer surface
of the plasma membrane,

02-

is released through the univalent reduction of

molecular oxygen, H202 by spontaneous dismutation of 02- , and after a
further univalent reduction of oxygen in H202, OH. is generated (Ellis,
1990). Unstimulated Ms have no detectable activity of the NADPH oxidase
(Sasada et al., 1983; McPhail and Snyderman, 1983).
The NADPH oxidase (extensively reviewed by Babior, 1987, 1988;
Segal, 1989; Gallin et al., 1991, Jesaitis and Dratz, 1992) constitutes a
transmembrane electron transport chain containing a flavoprotein and a
cytochrome

b5513,

with cytosolic NADPH as the donor and oxygen as the

acceptor of a single electron. This cytochrome has been purified and was
found to consist of two subunits, one 60- to 66-kDa and the other 22-kDa
subunits (Pick et al., 1990). Recent experiments have shown that two
cytosolic components of 47-kDa (p47Ph0 x) and 67-kDa (p67Ph0x) form a
complex with the cytochrome

b558.

In guinea pig Ms, it has been

demonstrated that the two cytosolic components interact with yet a third
cytosolic heterodimer, a small guanosine triphosphate (GTP)-binding
protein p21raP1 and the guanosine diphosphate (GDP)-dissociation inhibitor,
rhoGDI (Abo et al., 1991).
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The level of M. luminol-dependent chemiluminescence has been
demonstrated to be proportional to the rate of reactive oxygen
intermediates formation and thus directly reflects the activity of the
NADPH oxidase (Allen, 1986; Wymann et al., 1987; Tosk et al., 1989).
1.7. Signal transduction in macrophage activation by respiratory
oxidative burst
The identification of extracellular signals modulating cell behavior
is central to cell biology. Progress in this area may ultimately identify
pharmacologic agents capable of selectively modulating the function of
various cells. WI's are of particular interest as they have been shown to
play a significant role in host defense against microbes and tumors,
homeostasis, and disease such as carcinogenesis and atherogenesis. The
function of McOs in all these roles is stringently regulated by extracellular
signals (Adams and Hamilton, 1987, 1988a; Adams, 1989). Such signals
can stimulate the immediate execution of various complex functions which
include destruction of tumor cells by the release of reactive oxygen
intermediates (Adams and Hamilton, 1984, 1988a, b; Hamilton and Adams,
1987; Baggiolini and Wymann, 1990) or damage of normal cells and tissues
in inflammatory diseases (McCord, 1992). Other extracellular signals can
alter the potential of McPs so that competence to respond to extracellular
signals of the first type is markedly enhanced or diminished.
Physical and chemical changes in receptors, in the membrane itself,
and in other cellular structures occur following ligand interactions with
cell surface receptors (Fig. 1, Shapiro 1988; Jesaitis and Dratz, 1992).
The earliest detectable biochemical changes occur in seconds after the
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increase in number of occupied receptor sites following exposure of cells
to ligand. These include alterations in transmembrane Ca2+ and other ion
fluxes resulting in a change in pH and membrane potential (Shapiro, 1981;
Adams and Hamilton, 1987; Riches et al., 1988; Forman and Kim, 1989).
The major signal transduction pathways utilized by receptors on
eukaryotic cells are those that regulate activity of adenylate cyclase,
polyphosphoinositide-phosphodiesterase, or tyrosine kinase (Rigley and
Hicks, 1991). Emerging evidence (Klaus et al., 1987) indicates that these
second-messenger systems feedback on each other in both a negative and
positive way, suggesting that the summation of signals will drive an
appropriate response. Thus, it appears that the underlying complexities
controlling cell growth and activation lie not in the nature of the signal
generated but the manner in which these signals impinge on each other.
These difficulties are further compounded by the fact that, for IL-4mediated Mcl) activation, the types and modes of action of second and/or
third messengers are currently unknown.
We do know, however, a little about the signal transduction pathways
in phagocyte activation leading to the release of reactive oxygen
intermediates by chemoattractants. The signal transductional events of
leukocyte activation by reactive oxygen intermediates production has been
reviewed extensively (Snyderman et al., 1986; Sadler and Badwey, 1988;
Baggiolini and Wymann, 1990; Jesaitis and Dratz, 1992). Within seconds to
minutes, there may be changes in cyclic nucleotide concentrations,
increased protein phosphorylation, and alterations of membrane uptake of
sugars, amino acids, and fatty acids. In polymorphonuclear phagocytes, it
is known that receptor activation by chemoattractants induces
conformational changes in one or more G proteins (Verghese et al., 1987;
Baggiolini and Wymann, 1990; McPhail et al., 1992). The G protein then
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interacts with and activates a target enzyme, usually a phospholipase
(Snyderman et al., 1986; Gilman, 1987). Several phospholipases are
activated by chemoattractants including phospholipases A2, C, and D
(Verghese et at., 1987; Bauldry et al., 1988; Agwu et at., 1989). It is not
yet clear which phospholipases (A2, C, D) are directly regulated by or
interactive with a receptor-G protein, or whether the activation of the
other phospholipases is due to signalling through second messengers
generated by the first enzyme. The second messengers generated by
phospholipase activation (McPhail et al., 1992) include: 1) inosito1-1,4,5trisphosphate (IP3) (Berridge, 1987; Berridge and Irvine, 1989; Rana and
Hokin, 1990) and 1,2-diacylglycerol (DAG) (Berridge, 1987; Uhing and
Adams, 1989) by phospholipase C (PLC); 2) phosphatidic acid by PLO, and 3)
arachidonic acid by PLA2. Second messengers exert their signalling
effects by either activating target enzymes/receptors or metabolizing to
other products, some of which are inactive while others are active second
messengers. IP3 binds to receptors on intracellular calcium-storage
organelles and releases calcium (Lew, 1989). Targets for calcium include
protein kinase C (PKC) and calmodulin. DAG is a direct activator of PKC
(Ashendel, 1985) and can also synergize with certain amphiphiles for
activation of PKC, and can directly activate NADPH oxidase in a cell-free
system (Bellavite et al., 1988). In addition, phosphatidic acid and DAG can
be interconverted via the enzymes phosphatidic acid phosphohydrolase and
DAG kinase. Arachidonic acid can also directly activate NADPH oxidase in
a cell-free system (Heyneman and Vercauteren, 1984), as well as be
metabolized to the lipoxygenase products leukotriene E14 and 5hydroxyeicosatetraenoic acid. These products may bind to their cellsurface receptors causing further phospholipase activation (Verghese et
al., 1987; O'Flaherty et al., 1988).

17
The role of the kinases activated by second messengers in NADPH
oxidase activation is still not clear. The correlative approaches and/or
inhibitors used have, thus far, given contradictory results (Lambeth, 1988;
Tyagi et al, 1988; McPhail et al., 1992). PKC can induce activation of
NADPH oxidase in a cell-free system, but activation is much lower than
that obtained with amphiphiles. Several oxidase components, including the
cytosolic components p47Ph0X,

p21 rac-1,

and possibly cytochrome b558, are

phosphoprotein and targets for various protein kinases. However,
convincing evidence that phosphorylation of any of these proteins
modulates NADPH oxidase is lacking. Tyrosine kinase activity may also be
important for signalling by chemoattractants. Tyrosine kinases are
activated during stimulation by chemoattractants and cytokines, and
inhibitors of tyrosine kinases block stimulation of the respiratory burst by
these agonists (Gomez-Cambronero et al., 1989; Berkow et al., 1989).
However, no oxidase components are yet known to be substrates for
tyrosine kinases. Possibly, tyrosine kinases participate in an earlier
transductional step in the activation, such as during phospholipase
activation.
Later events, such as c-myc expression, synthesis of RNA, size
increases, and expression of cell-surface activation antigens, involve
more complex cell functions including activation of the nucleus and occur
within hours or days (Callard, 1991). Recently, IL-4 has been
demonstrated to induce the expression of c-myc and c-fos (Klemsz et al.,
1989; lsfort and Ihle, 1990).
At present, it is not known whether the signal transductional events
of IL-4-mediated Mcl) activation by respiratory oxidative burst is similar
to that of PMNs activated by chemoattractants. However, a single pattern
of ionic events has been observed in most of the cell activation processes
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which have been examined to date (Shapiro, 1981, 1988). Following ligand
binding to cell surface receptors, there is a rapid influx of Ca2+, usually
accompanied by release of intracellular "membrane-bound" Ca2+, and
resulting in a transient rise in free cytoplasmic [Ca2- ], which lasts for a
few minutes. There is also typically an increase in intracellular pH,
resulting from Na+/H+ exchange or antiport, which can be inhibited by
amiloride. Changes in membrane potential, when they are observed, can go
either in the direction of depolarization (decrease in transmembrane
potential) or hyperpolarization (increase in transmembrane potential) and
appear to be due primarily to Na+ and/or K+ shifts across the membrane.
1.7.1. Role of membrane potential
Resting cells maintain large gradients between intracellular and
extracellular concentrations of a variety of ions, including Ca2+, K+, Na+,
and Cl- (Shapiro, 1981, 1988). The relative permeability of the membrane
to K+ ions is greater than that to other ions; the leakage of K+ ions
establishes an electron countergradient and the cytoplasm becomes
electron negative with respect to the external medium. This K+
electrochemical gradient (Gallin and McKinney, 1988) is the most
significant contribution to the negative membrane potential of most
mammalian cells. Maintenance of a large negative transmembrane
potential has been postulated to be a control mechanism to arrest cells in
an inactive stage, and changes in cell membrane potential (which occur in
various cell types rapidly after binding of ligands to transmembrane
receptors) have been suggested to be mediators of subsequent physiologic
cellular responses. A confusing aspect of the study of lymphocyte
membrane potential following antigen receptor activation has been the
finding of either hyperpolarization (Tatham and Delves, 1984) or
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depolarization (Gambier et al., 1986). These differential effects may be
related to an inwardly directed calcium current (causing depolarization)
and to activation of calcium-dependent K+ channels (causing
•hyperpolarization). Heterogeneity among PMNs afte activation has been
reported with subpopulations which hyperpolarize and others which
depolarize (Seligmann et al., 1984). Other reports ndicate that there are
species differences in the Ca2 +-sensitive K+ channel activity; for
example, that Con A-induced activity of the calcium-dependent K+ channel
hyperpolarizes mouse thymocytes but cannot do so in pig lymphocytes
because the channel is already maximally activated (Felber and Brand,
1983). The role of membrane potential in IL-4-activated Ms was
determined by using a fluorescent membrane potential probe, 3,3'dihexyloxa-carbocyanine (D1006 (3), Shapiro et al., 1 1979; Lazzari et al.,
1986; Jenssen et al., 1986; Dwyer and Cuchens, 1987). The resting
membrane potential of adherent mouse peritoneal McPs and J774 mouse McP
cell line has been reported to be approximately -70mV (Sung et al., 1985).
In practice, a useful indicator should not itself perturb the
membrane potential, either by its very presence orL 'by cellular toxicity, and
changes in the partitioning of the indicator should be readily detectable.
Di0C6 (3), first described by Hoffmann and Laris (1974), belongs to a family
of cationic cyanine dyes (Appendix A), and is a liPophilic fluorescent
(green) dye having a single negative charge delocalized over an extensive
pi-electron system in a highly symmetric molecule. This charged
lipophilic molecule serves as an indicator of membrane potential, as it
partitions between the cell and surrounding medium according to the
Nernst equation:

[C]AC-1-10=e-nFE/RT
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where Co and Co are the cytosolic and extracellular DiPC6(3)
concentrations, E is the membrane potential, n (equals one) is the positive
charge of the cation Di0C6(3) and F, R and T are the Faraday and gas
constants, and temperature.
Once cells have been equilibrated with Di0C6:(3), depolarization of
the cells causes release of dye (decrease fluorescence in the cell) from
the cells into the medium, while hyperpolarization makes the cells take up
additional dye (increase fluorescence in the cell) from the medium
(Jenssen et al., 1986). Di0C6(3) does not adequately represent the new
value of membrane potential until equilibrium has Igain been reached; this
process requires about 5 minutes (min, Shapiro, 1988).
1.7.2. Role of calcium and 1P3
Calcium plays an important role as a mediator of transduction of
signals from the cell membrane; changes in intracellular free calcium
concentration ([Ca2+]) are part of the regulation of ; diverse cellular
processes (Whitfield, 1990). In PMNs, Ca2+ has been demonstrated to be
required for the induction of respiratory burst since cells depleted of their
Ca2+ storage pool fail to produce 02- or H202 in response to agonists
unless extracellular calcium is supplied (Lew et al , 1984). However, it
appears that influx of extracellular calcium is not essential for the
induction of respiratory burst since the induction cannot be prevented by
chelation of extracellular Ca2 +. Interestingly, the influx of extracellular
calcium does contribute to the overall rise in [Ca2 ] (VonTscharner et al.,
1986).
Eukaryotic cells have an internal calcium ion concentration that is
usually maintained at 100 nM (June and Rabinovitchr, 1988), far below the
extracellular environment, by regulation of calcium channels within their
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plasma membranes, and of storage and release of Ca2+ from intracellular
sites such as calciosomes, endoplasmic reticulum and mitochondria
(Rasmussen, 1986; Volpe et al., 1988). The transfer of calcium across the
plasma membrane is regulated by calcium channels which may be voltage
gated or receptor operated, the 3Na+/Ca2+ antiport, and the Ca2 +/2H+ATPase pump. Cellular calcium homeostasis is ma'ntained by the
Na+/Ca2+ antiport (a high capacity, low affinity system) and the Ca2+/H+ATPase pump (a low capacity, high affinity system); both extrude calcium
in order to maintain [Ca2+] within a narrow range.

Plasma membrane

calcium influx is thought to be initiated by membrane depolarization which
opens voltage-gated channels or by the binding of ligands to receptor
operated channels. The binding of agonist to its specific membrane
I
receptor causes the activation of a guanine nucleotide binding protein
(Snyderman et al., 1986; Gilman, 1987) which, in turn, activates PLC. PLC
causes the hydrolysis of a membrane phospholipifl, phosphatidylinositol
4,5-bisphosphate, which yields water soluble IP3 (Berridge, 1987; Berridge
I
and Irvine, 1989; Rana and Hokin, 1990) and a lipid DAG (Berridge, 1987).
I
IP3 and perhaps additional products of IP3 metabolism, then cause the
I
release of calcium from intracellular stores while DAG, at the membrane
I
and in conjunction with calcium ions, activate PKC (Kikkawa et al., 1989).
I
The resulting phosphoprotein (phosphorylated by PKC) and Ca2+ may be
necessary for the stimulation of NADPH-oxidase (Curnette, 1990; Nath and
Powledge, 1990; Pick et al., 1990; Rotrosen et al., 1990; Segal, 1990) thus
reducing 02 to 02-. Ca2 + itself has a broad range of effects, activating a
variety of enzyme systems, both as a cofactor and in conjunction with the
calcium binding protein calmodulin. While it appears clear that the initial
elevation of ionized calcium is due to the release of intracellular calcium
stores, little is known about the regulation of the influx of calcium from
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extracellular sources that is necessary to sustain the response. Recent
evidence indicates two additional products of IP3, inositol 1:2-cyclic 4,5trisphosphate and inositol 1,3,4,5-tetrakisphosphate, also have second
messenger function in that they are active in mobilizing cellular stores of
calcium (Zilberman et al., 1987; Luckhoff and Clapham, 1992). The
production of inositol 1,3,4,5-tetrakisphosphate may be regulated in part
by cytosolic calcium concentration.
1.7.2.1. Measurement of change in calcium with indo-1
An optimal indicator of [Ca2 ] should span the range of calcium
concentrations from 100 nM to above a micromolar, with greatest
sensitivity to small changes at the lower end of that range. The response
to transient changes should be rapid and the indicator should freely diffuse
throughout the cytoplasm, but be easily and stably loaded. Finally, the
indicator itself should have little or no effect upon [Ca2- ]; or on other
cellular functions and must not be toxic to the cell. Grynkiewicz et al.
(1985) have described a new family of highly fluorescent indicators of
[Ca2 ] which overcome most of these difficulties.
Indo-1

([1-[2-amino-5-[carboxylindo1-2-y1]-phenoxy]-2-2'-amino-5'-

methylphenoxy)-ethane-N,N,N',N'-tetraacetic acid) has spectral properties
and, therefore, is the choice indicator for flow cytometry applications, in
which the limited excitation wavelengths make monitoring two different
emissions more practical (Molecular Probes Handbook, 1989). The
hypsochromic shift of indo-1 in absorption and excitation spectra upon
binding Ca2+ is well understood (Tsien, 1980). In order for the nitrogens
(together with their attached acetate groups and the ether oxygens) to
envelope and chelate a Ca2+ ion (Appendix B), the nitrogen ring bonds would
have to twist by nearly 900 , breaking the ring conjugation (485 Km) and
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giving a spectrum of a simple benzene (405 nm). lndo-1 is asssociated
with a 1:1 Ca2+ binding stoichiometry and binds with a rather quick
association constant of 5 x 108 - lx 109 M-1 s-1 (Jackson et al., 1987).
Rabinovitch et al. (1986) demonstrated that in lymphocytes loaded with
indo-1, the loss of blue and violet fluorescence is about 10% while the
ratio of violet to blue fluorescence loss is only about 4% at 25°C for 4 h.
Thus, indo-1 loaded cells are remarkably stable.
1.7.2.2. Advantages of indo-1 over other [Ca2+1; indicators
As compared to other [Ca2 ] indicators, indo-1, 1) does not have as
high an affinity for calcium and, therefore, does not perturb cellular
calcium metabolism nearly as much as quin-2, for example; 2) is
introduced into cells in the form of the permeant indo-1 acetoxymethyl
ester (AM) form, which undergoes hydrolysis by non-specific esterase in
living cells to yield the free dye; 3) has 30-fold greater quantum yield in
terms of fluorescence than quin-2 at a given dye concentration
(Grynkiewicz et al., 1985); 4) compared to quin2 is more selective for
divalent cations (selects for Ca2+ 105 more than for Mg2+) and is not
quenched by heavy metals which are found in the cytoplasm of some cell
lines; 5) undergoes substantial emission spectral shifts upon binding
calcium; 6) makes ratiometric measurements of cytoplasmic [Ca2-1 ]
possible (which cancel out many extraneous factors including uneven
illumination, light source noise and the effects of cell-to-cell variations
in dye content; the degree of dye loading is independent of dye
concentration, cell thickness, photobleaching and dye leakage, as long as
free dye is washed away); 7) is remarkably nontoxic to cells subsequent to
loading; and 8) discriminates between live and dead cells as the latter do
not retain the hydrophilic impermeant dye.
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1.7.3. Role of cAMP
It has been known for many years that an accumulation of cAMP
exerts either a positive or negative effect on cell activation and growth
(Klaus et al., 1987; Rigley and Hicks, 1991). However, it has recently been
shown that IL-4 induces the activation of adenylate Oyclase which leads to
the increased expression of cluster of differentiation (CD)23 (high affinity
receptor to IgE) on B cells (Finney et al., 1990). The, requirement of
adenylate cyclase activation for signal transduction has been well
established in cells possessing receptors for growth factors and hormones
(Sutherland and Rall, 1960; Rickley and Hicks, 1991). To determine, the
role of the second messenger cAMP in the production of reactive oxygen
intermediates in IL-4-mediated M. activation, a series of experiments
were performed (Chapter 8, Tan et al., 1992b). It is known that cAMPdependent protein kinase (Kammer, 1988; Taylor et al., 1990) can
phosphorylate substrate protein containing serine, threonine, or tyrosine
residues. Further introduction to the role of cAMP is briefly described in
Chapter 8 (Tan et al., 1992b)
1.8. Known IL-4-mediated signal transduction
The mechanism of signal transduction by IL-4 is not clear and has
recently been reviewed by Harada et al. (1992). Involvement of
phosphatidylinositol turnover, increase in intracellular calcium, cAMP, and
PKC activation in the IL-4 signal transduction pathway is controversial.
Mizuguchi et al. (1986) demonstrated that IL-4 on resting B cells does not
require elevation of inositol phospholipid metabolism or increased
calcium. However, it has been demonstrated that IL-4 activates human B
lymphocytes via a transient inositol lipid hydrolysis (Finney et al., 1990),
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an increase in calcium (Finney et al., 1990; Ashida et al., 1990), and a
delayed cAMP generation (Finney et al., 1990). Finney and colleagues
suggested that this is in contrast to that of previous results because
different sources of B lymphocytes were used, and the very rapid and
transient increase in calcium may not have been recognized. Interestingly,
Finney et al. (1991) and Galizzi et al. (1988) found that IL-4 does not have
an appreciable effect on cAMP levels in IL-4-mediated CD23 expression by
murine B cells or the human B cell line Jijoye, respectively. Justement et
al. (1986) and Dancescu et al. (1992) demonstrated that IL-4 did not
stimulate PKC translocation from cytosol to membrane in resting murine B
cells and that IL-4 regulates the expression of CD20 by B cells through a
PKC-independent pathway. In contrast, Chaikin et al. (1990) have reported
that IL-4 increased PKC activity in the membrane fraction of mouse bone
marrow-derived mast cells. One possible explanation for these
dichotomous results is that IL-4 may bind to at least two functionally
distinct types of receptors on target cells (Mosley et al., 1989; Finney et
al., 1991). Recent data have suggested that there exist two separate
signal transduction pathways stimulated by IL-4 in B cells, one that is
dependent (IL-4-induced expression of CD23) and the other independent
(IL 4-induced expression of sIgM) of the hydrolysis of phosphatidyl
inositol 4,5-bisphosphate and generation of cAMP (Rigley et al., 1991).
One could assume, therefore, that each signal transduction pathway is
coupled to a distinct IL-4R subtype or that IL-4R signalling in different
cells may involve distinct intracellular activation pathways (Nikcevich et
al., 1992). An alternative explanation is that there may exist a single type
of IL-4R (since only a single high affinity type has been isolated) that
interacts with multiple signal transduction components (each different
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type of cell using a unique component) which transmit different
intracellular signals.
In some factor-dependent mouse myeloid cells, IL-4 clearly induces
protein tyrosine phosphorylation within 10 min, suggesting a possible
involvement of a tyrosine kinase in 1L-4 signal transduction (Mona et al.,
1988; lsfort and !hie, 1990). However, Nikcevich et al. (1992)
demonstrated that IL-4 stimulated tyrosine phosphorylation in some
murine T cell lines but not in others. Collectively, these data suggest that
IL-4R signalling in different cells may involve distinct pathways.
Interestingly, ldzerda et al. (1990) demonstrated that the cytoplasmic
domain sequence of human IL-4R possesses no sequence homologies with
protein kinases or sequences found at phosphorylation acceptor sites for
protein tyrosine kinases or PKC. They also demonstrated that the murine T
cell line, GILL, which is stably transfected with the human IL-4R cDNA,
proliferated in response to human IL-4. These results indicate that the
molecularly cloned human IL-4R protein is able to interact with the mouse
signal transduction machinery. Interestingly, about 400 amino acid
residues that form the C-terminus can be deleted without loss of the
biological function of the human IL-4R in mouse stable transfectants,
indicating that the restricted region of the IL-4R is required for
interaction with a signal transducing molecule(s) for proliferation (Harada
et al., 1992). Recently, IL-4 has been demonstrated to induce the
expression of c-myc and c-fos (Klemsz et al., 1989; Isfort and 'hie, 1990),
protooncogenes known to be involved in cell activation and proliferation.
1.9. Goals and objectives of the project
In view of the dismal clinical results in treating pancreatic cancer
(Tan and Strong, 1986; Tan et al., 1987a, b), the goal of our early research
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had been to develop in vitro and in vivo hamster models in which protocols
applicable to the treatment of epithelial cancers, e.g. pancreatic cancer,
could be tested. The hamster model was chosen because pancreatic cancer
induced in Syrian Golden hamsters with the PC-1 transplantable pancreatic
cancer cell line has been shown to share many characteristics with the
equivalent human disease (Pour et al., 1981; Egami et al., 1989). A series
of experiments were performed to activate hamster peritoneal Ms with
IL-4 to release free reactive oxygen intermediates (Chapter 4, Tan et al.,
1991b).
In mid 1987, it was not known whether murine 1L-4 is speciesspecific or will cross narrow phylogenetic barriers for biological activity
on hamster M4)s. However, it was found later that there is no species
cross reactivity between murine IL-4 and human cellls, and human 1L-4 and
murine cells (Mosmann et al., 1987; Ohara and Paul, 1987) although both
human a-4 and murine

cDNA clones share 50% homology at the

amino acid level (as inferred from nucleotide sequence; Yokota et al.,
1988) and exhibit similar activities in many instances. Later, Leitenberg
and Feldbush (1988) found that murine IL-4 will not induce class 11 MHC
antigen expression on rat B cells. To determine the species specificity of
murine IL-4, a series of experiments was undertaken to determine if
murine IL-4 could activate hamster and rat peritoneal Mts (Chapter 4, Tan
et al., 1991b).
Next, the biological activity of IL-4 on murine peritoneal WI:0s was
further characterized (Chapter 5, Tan et al., 1990, 1991d). In this study,
the M4-activating properties of murine 1L-4 on the formation of reactive
oxygen intermediates was evaluated by monitoring zymosan-triggered
chemiluminescent oxidative burst. It was reported that IL-4 induced a
dose-dependent enhancement of chemiluminescence in murine peritoneal
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M4)s triggered with zymosan. In contrast, IL-4 inhibited the zymosantriggered chemiluminescence in the J774 murine M4) cell line.
Further work was undertaken to develop a model which could suitably
replace the use of murine peritoneal M4)s (Tan et al., 1991a, 1992b). The
bone marrow-derived M4) (BMM4)) cell line, 14M1.4, responds to 1L-4 in a
manner similar to murine peritoneal Ms but has advantages that include
shorter kinetics for response, better reproducibility, shorter preparation
time, and avoids the use of animals. These characteristics enabled me to
study the signal transduction mechanism of M4) activation by IL-4 (Chapter
6-8; Ralph, 1981, 1986; Tan et al., 1991c; Tan et al., 1992b). Thus, in
using the 14M1.4

Bmmt and J774 M4) cell lines as models, it became

possible to study the contrasting effect of IL-4 on the respiratory
oxidative burst. The yet unknown signal transduction mechanisms of IL-4mediated M4) activation was determined at the second/third messenger
levels. Using the 14M1.4 Ms, the change in membrane potential (Chapter
6) and the role of IP3 and calcium (Chapter 7), and cAMP (Chapter 8) as
possible mediators of transduction signals in IL-4-activated Ms were
investigated. An attempt to correlate the tumoricidal activity to the
release of reactive oxygen intermediates in IL-4-mediated M4) activation
in 14M1.4 and J774 Ms was done by assaying cytolysis and cytostasis of
tumor target cells (Chapter 9).
Beyond the scope of this dissertation, the long-term goal of this in
vitro study is to determine a protocol whereby mononuclear phagocytes are
activated in vivo by IL-4 to kill host tumor cells. Difficulty in studying
this is expected, however, because it is known that IL-4 (and other
lymphokines), when administered systemically, manifest a very brief halflife. For example, in cancer patients receiving IL-2 (Koths and Halenbeck,
1985), the most well studied lymphokine, and IL-4 (Custer and Lotze,
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1990), the a distribution phases are approximately 5 and 8 min,
respectively, followed by apparent 13 clearance phases , of approximately
30-40 and 48 min, respectively. One way to circumvent the problem of a
short half life would be to deliver liposome encapsulated 1L-4. These
liposomes would be recognized and engulfed by Ms, the first line of
immune defense (Cohn, 1986). Of course, the success of this proposal will
work only if Ms possess cytosolic receptors for IL-4. The concept of
using M.4) activating factors, e.g. KO lipopolysaccharide derivatives,
encapsulated in liposomes has • been demonstrated to be successful
(Kleinerman et at., 1983; Kleinerman and Fidler, 1985; Sone et at., 1985;
Fidler, 1985, 1989). If such a treatment regimen were applicable in vivo,
it might comprise a new therapy regimen for patients diagnosed as having
cancer. Another alternative might be to conjugate 1L-4 to tumor-specific
or tumor-associated mAb. As early as 1985, Oldham had shown that mAb
diffuses well into the tumor module and suggested that it could provide an
appropriate delivery system.
More immediate goals (not included in this dissertation) would be the
identification of the specific mechanism(s) by which IL-4-activated McPs
kill tumor cells. Since chemiluminescence is a reflection •of the entire
release of many reactive oxygen intermediates by activated Ms, it is not
known specifically which reactive oxygen intermediates (for example,
hydrogen peroxide vs superoxide anion) is released from IL-4-mediated
activated Ms. It would be interesting to note which of these reactive
oxygen intermediates are required for IL-4-mediated Mchumoricidal
activity. In addition, it has previously been demonstrated that cytolytic
proteases are necessary for MI's to bind tumor cells and to develop
competence for cytolysis of neoplastic targets (Adams, 1980; Johnson et
al., 1983). Recently, reactive nitrogen intermediates generated by
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enzymatic deimination of L-arginine by murine MSs (Hibbs et al., 1987;
Stuehr and Nathan, 1989) and a tumoricidal glycoprotpin (170-kDa)
secreted from cultured murine bone marrow-derived Ms (Schwamberger
et al., 1992) have been implicated in M. tumoricidal effector mechanisms.
Thus, it would be interesting to note if IL-4-activated M s kill tumor cells
by the reactive oxygen and nitrogen intermediates pathway or by yet
uncharacterized tumoricidal proteins, or both.
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2.1. ABSTRACT
The discovery of IgE is considered the most important
contribution, to date, in the field of clinical allergy. Studies in
rodents and humans have suggested that IgE production could be
regulated by antigen-specific helper and suppressor T cells, and
by isotype-specific factors having affinity for IgE. In recent
years, the synthesis of IgE has been shown to be regulated, in
part, by a cytokine network. This review summarizes the
cytokines that upregulate (IL-4, IL-5 and IL-6i and downregulate
(1FN-y and IL-2) the production of IgE. Emphasis is placed on
1L-4 and IFN-y,, two lymphokines known to play a major, but
reciprocal, role in IgE synthesis. Increased insight into the
various IgE control mechanisms by cytokines and their receptors
will eventually lead to improved treatment strategies in the
clinical management of IgE-mediated allergy.
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2.2. INTRODUCTION
The incidence of patients presenting with IgE-Mediated allergic
diseases is increasing. Currently, these diseases affect about 10% of the
world population and represent a major socioeconomic problem (1).
Allergic diseases are characterized by a consistently" elevated synthesis
of IgE upon stimulation by environmental allergens. The recognition of
allergen by the immune system, in a simplistic fashion, is accomplished by
class II-MHC-positive cells and specific T helper lymphocytes (2). The T
cells, following activation, induce B cells to produce allergen specific IgE
(3). The secreted IgE binds preferentially to high affinity FCE receptors
(Fc€111) on mast cells and basophils, thus sensitizing them. The Full are
cross-linked upon a second encounter with the allergen. This sequence of
events (summarized in Fig. 1) results in the release of histamine,
leukotrienes, and other pharmacologic mediators from the sensitized cells
and is responsible for Type I immediate hypersensitivity.

2.3. THE REGULATORY ROLE OF 1L-4
Coffman and colleagues (4) first reported that 1 the T cell-derived
lymphokine IL-4 was able to induce IgE production in vitro by costimulation of murine B cell blasts. IL-4, originally described as a B cell
growth factor, has subsequently been shown to have pleiotropic effects on
multiple hematologic and nonhematologic cellular lineages (5,6,7). The IgE
inducing effect of 1L-4 initially observed in vitro was confirmed by in vivo
studies showing that the administration of an IL-4 monoclonal antibody
inhibited 99% of the primary IgE response (8). This 'group further
demonstrated that 1L-4 is unequivocally required for ,an in vivo primary IgE
response and that IL-4 also plays a major role in the secondary chronic
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production of IgE. The secondary response was not completely inhibited by
anti-IL-4 and is thought to be due to the formation of la memory pool of
IgE-producing cells.
Direct evidence linking 1L-4 to the allergic response was provided by
Tepper et. al. (9) when they fused the IL-4 gene to an immunoglobulin
promoter/ enhancer gene and made a transgenic mouse model that
incorporated this modified product. Overexpression of 1L-4 resulted in a
marked increase in serum IgE levels and histopathologic features seen in
typical allergic reactions. Supporting evidence that 1L-4 plays a key role
in the regulation of IgE synthesis was soon provided ; by additional reports
in humans (10). Exogenous IL-4 (100U/m1), could induce IgE synthesis by
peripheral blood mononuclear cells (PBMC) in normal , individuals but not in
atopic patients (11). The important response parameter being that of a
baseline serum IgE level of <10,000 IU/m1 (12). One explanation for these
findings might be that atopic individuals are near a maximal stimulation
level in vivo and are, therefore, less responsive than normal healthy
individuals to the further addition of IL-4.
Another important role unique to 1L-4 is the induction of low
affinity FCE receptors (FcE All or CD23) expressed on normal human B
lymphocytes, a function originally thought to be critical to the production
of IgE by B cells (13,14). A relatively low concentration (3-5 Wm!) of
IL-4 is sufficient for CD23 expression but the concentration of IL-4
required for immunoglobulin class switching to IgE synthesis is much
higher than physiologic levels (15,16). The concentration of IL-4 needed
(5-10 U/ml) for IgE synthesis can be diminished to near physiologic levels
by the addition of IL-5 (17).
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A two signal model for the induction of IgE has been proposed
(14,18). One of the two signals is delivered by IL-4, and is IgE isotype
specific. However, it appears that IL-4 alone is not sufficient to induce
IgE synthesis in B lymphocytes. The other mandatory signal is primarily
provided by physical interactions between T and B cells either through the
TCR and/or surface molecules expressed on activated T cells. This signal
can also be furnished by An increasing list of B cell activators that include
EBV infection (19), anti-CD40 antibody (20), and hydrocortisone (21).
Again, neither EBV infection, hydrocortisone, nor anti-CD40 alone induced
IgE synthesis in the absence of 1L-4.

2.4. THE REGULATORY ROLE OF IFN-y
Many studies have demonstrated that 1FN-y downregulates IgE
production and IL-4-promoted CD23 expression in vitro. As early as 1986,
Coffman et. al. (4) provided data that suggested IgE production could be
inhibited by IFN-y. In subsequent years, Pene and colleagues (10) showed
that IFN-y can inhibit 1L-4-mediated IgE production by normal human
lymphocytes. The role of IFN as an inhibitor of IgE production is further
supported by recent clinical trials. Treatments with IFN-y in vivo
significantly lowered the IgE serum levels of hyper-IgE syndrome patients
(22). Similar treatments in atopic dermatitis patients showed clinical
improvement and a reduction in the spontaneous in vitro synthesis of IgE;
no effect on serum IgE levels was noted (23). Taken together, these data
would suggest that IFN-y is a potent suppressor of the IgE response in
vitro and that it is likely to exert a similar effect in vivo.
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2.5. THE REGULATORY ROLE OF OTHER CYTOKINES
IL-2 has recently been demonstrated to be required for IL-4
1
production by T cells (24) and unpublished data of PeIne (25) suggested that
IL-2 may upregulate IL-4-induced IgE synthesis. Hosivever, patients with
severe atopic dermatitis receiving 1L-2 intravenously showed a clear
therapeutic effect although there were no significant changes in serum
IgE, or in in vitro IgE production (26). This therapeutic effect has been
supported by in vitro experiments of Spiegelberg (27) in which IL-2 was
seen to inhibit IL-4-induced IgE synthesis of PBMC from normal and atopic
dermatitis patients.
Other lymphokines, in particular, IL-5 and IL-6, have been
demonstrated to upregulate the IgE response induced by IL-4 (17,25,28).
That IL-6 enhanced the production of IgE appears to explain the
potentiating effect of monocytes (29).
Other growth factors such as TGF-j3 and IFN-c( have been reported as
inhibitors of IL-4-promoted IgE production and also' of IL-4-promoted
CD23 expression by B cells (10,30,31).
Mast cells play an important role in the efferent arm of the allergic
response. As outlined in the introduction, these cells bind IgE through the
FcE RI and are subsequently activated by allergens leading to the release of
allergic mediators. Mast cells have been shown to produce cytokines,
including IL-3, IL-4, IL-5, and IL-6 (32). This ability of mast cells to
secrete and respond to cytokines has important consequences in
autoregulation within the allergic response; 1L-3 and IL-4 stimulate the
' th of eosinophils (33).
growth of mast cells while IL-5 stimulates the grow
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2.6. THERAPY WITH RECOMBINANT SOLUBLE CYTOKINE RECEPTORS
1
Rational therapeutic approaches are now possible due to our
1
understanding of the mechanisms that trigger IgE synthesis in B cells.
IL-4 activates IgE producing B cells through an interaction with a specific
membrane glycoprotein, the IL-4 receptor (IL-4R) (34).. With the advent of
recombinant soluble (s)IL-4R molecules [mouse (35,6,); human (37)], it is
conceivable that sIL-4R can be used to modify IL-4i pi'oduction in patients
with IgE-mediated allergy. The working hypothesis is that sIL-4R will
competitively bind and offset the effect of excess IL-4, thus
downregulating IgE synthesis by B cells.
Ideally, recombinant soluble receptors could provide the means for a
specific and potent immunosuppression. Soluble IL-414, having at least
100- to 1000-fold higher affinities for 1L-4, would be superior to IL-4 and
IL-4R monoclonal antibodies in that the soluble receptors are smaller and
will allow for better tissue distribution (38). For example, in a cardiac
allograft model, a 0.015mg/kg total dose of sIL-4R was found to inhibit •
50% of the peripheral lymph node response to allogeneic cells in vivo,
whereas a 300mg/kg total dose of anti-1L-4 or 18.8 mg/kg total dose of
anti-IL-4R was required to cause the same amount of inhibition (39). In
general, soluble receptors would not be recognized as foreign by the
immune system such as in the case of monoclonal antibodies raised in
different species (40). Additionally, they do not have specific structures
1 "
reacting with immune cells as would the Fc portion, if immunoglobulins.
,
Low levels of sIL-4R have been detected in the blood and urine of
mice and in concentrated culture supernatants of purified murine T and B
cells (38,41). The presence of sIL-4R in these bodyl fluids may in fact be a
physiologic control mechanism to fine tune the proci4tion of IL-4. Low
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concentrations of purified s1L-4R specifically inhibited IL-4-mediated
proliferation in vitro, suggesting its utility as a possible therapeutic
agent (36,37). The finding that IL-4 inhibitory agents in humans might
abrogate the IgE response without affecting the levels of other isotypes
(8) provided support for the therapeutic application of s1L-4R. Recent in
vivo results have indicated that the kinetics and affinity of 1L-4 binding to
the recombinant sIL-4R are similar to the native membrane bound 1L-4R
(36). It is important to note that therapeutic intervention with IL-4R
should not be used to completely abrogate IgE antibodies in vivo since it
has been demonstrated that IL-4-induced IgE antibodies may be beneficial
(42).
Taken together, IL-4 appears to be the major cytokine that
upregulates IgE production since the other cytokines, by themselves, had
no effect on IgE synthesis. These molecules however could enhance the
IL-4-induced IgE production. With an increased insight into the various IgE
control mechanisms by cytokines and their corresponding receptors, it is
conceivable that improved treatment strategies in the clinical
management of IgE-mediated allergy can be formulated.
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CHAPTER 3

MATERIALS AND METHODS OF UNPUBLISHED WORK

3.1. Reagents
Bovine serum albumin (BSA)-globulin free, gramicidin, luminol,
penicillin, saponin, streptomycin, trypsin, valinomychli , zymosan, EGTA,
LPS, PLC, ethylenediaminetetraacetic acid (EDTA), dimethylsulfoxide
(DMSO), phorbol myristate acetate (PMA), prostaglandin (PG)E2, sodium
dodecyl sulfate (SDS), 3-isobuty1-1-methylxanthinej tri-n-octylamine,
1,1,2-trichlorotrifluoroethane, and 3-[4,5-dimethyllthiazol-2-y1]-2,51
diphenyltetrazolium bromide (MTT) were purchased from Sigma (St Louis,
MO). Anhydrous DMSO was purchased from Aldrich (Milwaukee, WI);
Proteose peptone from Difco (Detroit, MI); Di0C6(3), indo-1AM and BAPTAAM (1,2-bis-[2-aminophenoxy]-ethane-N,N,N1',N'-tetraacetic acid,
acetoxymethyl ester) from Molecular Probes (Eugenet OR); Roswell Park
Memorial Institute (RPM') 1640, Hanks' balanced salt solution (HBSS), fetal
calf serum (FCS), phosphate-buffered saline (PBS) from Irvine Scientific
(Santa Ana, CA); lonomycin from Calbiochem (San Diego, CA); [methyl- 311]thymidine and Biofluor emulsifier cocktail from New England Nuclear
(Boston, MA); and IP3 and cAMP [3H] assay system from Amersham
(Arlington Heights, IL).
Murine. a-4 was kindly provided by Dr. Stever' Gillis (Immunex
Corporation, Seattle, WA, and Sterling Winthrop Pharmaceuticals, Malvern,
PA). This protein had a specific activity of 108 U/nig; 1 U is the
concentration of IL-4 required to half-maximally stimulate the uptake of
[methyl-311]-thymidine by 5 X 104 resting splenic B cells costimulated
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with 5 µg/m1 of purified anti-IgM antibody, a standard antiimmunoglobulin comitogenesis assay (Grabstein et al. 1986b).
Anti-IL-4 was obtained from TexStar Monoclonals (Dallas, TX) and
Geniyme (Boston, MA). It is an IgGi K affinity-purified mAb from 11B115E3
hybridoma culture supernatant. 11B115E3 is a high producer subclone of
11611 which is the original clone Ohara and Paul (1985) produced against
murine rIL-4 in Lew/Sn rats. This anti-IL-4 mAb blocked the biological
!
activity of IL-4 as measured in HT-2 proliferation, B cell differentiation
factor-y, and B cell growth factor 1 anti-Ig-costimulation assays.

Anti-

IL-4 has an 1050 (50% inhibition of a 50% maximal response
in a IL-4 anti; ,
lg-costimulation assay) of 0.006 µg/ml. For neutralization of mouse IL-4
1
bioactivity, it was found that 8 µ,g of the anti-1L-4 mAb was sufficient to
inhibit 100% of the bioactivity of 100 U rIL-4 (Tan et al., 1991d). Anti,
IL-4 obtained later from NCI-FCRDC, courtesy of Hazleton Labs (Vienna,
VA), had similar biological activity.
3.2. Animals and cell lines
Male Balb/c mice, Sprague Dawley rats, and Syrian golden hamsters,
8-12 weeks old, purchased from Charles River Laboratories (Wilmington,
MA), were pre-screened and found to be negative for bacterial pathogens,
parasites and subclinical viral infections.
The cell lines used were: 1) L1210, a mouse lymphocytic leukemic
cell line from American Type Culture Collection; 2) PDPaCa, a hamster
poorly differentiated pancreatic carcinoma cell line Chang et al., 1987);
3) H238, a murine fibroblast cell line (Boyd and Orme, 1975); 4) J774A.1, a
mouse monocyte-M4) cell line from American Type Culture Collection TIB
67, was generously provided by Drs. Lau and Tosk of LLU,. Department of
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Microbiology; and 5) 14M1.4, a BMW!) cell line, was a gift from Dr. A.
Zlotnik (DNAX, Palo Alto, CA).
3.3. Cell culture conditions
Nondetectable endotoxin (<0.01 ng/ml) RPMI 1640 medium (Moore et
al., 1968; Ham and McKeehan, 1979, Irvine Scientific, Santa Ana, CA,
Appendix C) was supplemented with 10% FCS (nondetectable endotoxin,
Irvine Scientific, Santa Ana, CA), 100 U/ml penicillin, and 100 Ltg/m1
streptomycin (hereafter known as complete medium, CM). CM for each
experiment was sterilized with 0.22 µIn filter and made fresh frequently
since L-glutamine is unstable and has a half-life in medium at 4°C of 3
weeks, and at 37°C of 1 week. Overall health of the cultures were
ascertained daily by inspecting all cultures by inverted phase microscopy.
All cell lines lines were subcultured every 4-6 days for two months. To
avoid potential problems developing in subcultures maintained for
prolonged periods, a large number of ampules of cells were frozen and new
stock cultures initiated (Appendix D) approximately every 2 months. When
the cells were confluent (about once every 5 days), they were split
(Appendix E) to create fresh subcultures of approximately 1:5 to 1:10 cells
in fresh CM. Media were changed approximately 2-3 times a week, using
prewarmed CM.
Mycoplasma contamination (Callard et al., 1987)
Mycoplasma contamination can affect tumoricidall assays in many
different ways.

In particular, interpretation of [methyl- 31-1]-thym id ine

incorporation results may be impossible if the responding cell lines are
contaminated. To prevent mycoplasma contamination, in addition to using
sterile techniques and working within a laminar flow hood which had been
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exposed to UV light when not in use, the laminar flow cabinet was
frequently fumigated with formaldehyde overnight. MYCOTRIM TC (Hana
Biologics, Alameda, CA) was used to screen and monitor continuously
passaged cells for mycoplasma contamination (Appendix F) once every two
months and again before freezing stocks of cell lines. Each new lot of
serum, trypsin, and medium, as well as newly acquired cell cultures, were
tested for mycoplasma contamination before use. Fortunately, there was
no known mycoplasma contamination throughout the entire research
training.
3.4. Macrophage preparations.
3.4.1. J774 macrophages
This cell line was adapted to culture from a tumor which arose in a
female Balb/c mouse in 1968 during a plasmacytoma induction program
(Hirst et al., 1971; Ralph et al., 1975). The J774 Ms, similar to that of
murine peritoneal M4)s, have been demonstrated to be chemotactic and
phagocytic (Snyderman et al., 1977). J774 M4:is adhere to plastic and
exhibit antibody-dependent cellular cytotoxicity, produce lysozyme and
possess Fc receptors (Ralph et al., 1975; Ralph et al., 1976; Snyderman et
al., 1977; Kaplan and Morland, 1978). However, this cell line releases
higher levels of acid phosphatase and 13-glucoronidase and is more
sensitive to LPS than normal murine peritoneal Ms, indicating that the
tumor cells are more "activated" (Morland and Kaplan, 1978). It has been
shown that cell growth can be inhibited by dextran sulfate and LPS (Ralph
and Nakoinz, 1977), and that IL-1 is synthesized continuously (Ralph et al.,
1976) by this line.
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M4)s were grown in CM at 2-3 x 105 cells/ml (Adams and Edelson,
1981) in 25 x 125 mm disposable sterile polystyrene petri dishes that
contained a thin, transparent flourocarbon Teflon film (FEP, type A; Welch
Fluorocarbon, Medway, MA) allowing Mots to adhere rapidly yet disengage
easily without trypsinization (VanderMeer et al., 1981; Helinski et al.,
1988). The Teflon film had been vacuum-formed as to provide a liner for
the petri dish.
3.4.2. 14M1.4 macrophages
14M1.4, a BMM, cell line, is derived from adherent bone marrow cells
of Balb/c origin (Zipori et al., 1984). These cells were termed Ms
because they exhibit the morphology of Ms and are able to phagocytize,
process and degrade antigens. They also possess enzyme characteristics
of Ms such as alpha-naphthyl butyrate esterases, acid phosphatases, and
peroxidases (Diesselhoff-denDulk and VanFurth, 1981). This cell line
requires MCSF to survive and replicate at low cell concentrations
(‘. 2 x 104 /m1); however, at higher cell concentrations, it is able to survive
without external sources of MCSF (Zipori et al., 1984; Tan et al.,
unpublished observation). In all experiments, 14M1.4 Mi)s were grown at a
density of >1 x 105/m1 (Adams and Edelson, 1981) in the absence of MCSF,
and in teflon-coated petri dishes as with J774 Mts (VanderMeer et al.,
1981; Helinski et al., 1988).
3.4.3. Peritoneal macrophages
Peritoneal exudate cells (M40-rich) were collected from Balb/c mice,
Sprague Dawley rats, and Golden Syrian hamsters which had received 3 ml
sterile 3% proteose peptone (Difco, Detroit, MI) i.p. 3 days previously.
Cells were collected by peritoneal lavage (Appendix G) with CM containing
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10 lliml heparin (Ruco and Meltzer, 1978; Meltzer, 1981a; Herbert et al.,
1986; Crawford et al., 1987). Three percent proteose peptone had been
prepared by dissolving 15 g of proteose peptone in 500 ml of pyrogen-free
PBS, dispensed into 15 ml polypropylene tubes, autoclaved (15 psi, 121°C,
15 min), cooled, and stored at 25°C. Ms harvested from 1-3 animals
(>3-20 X 106 McPs per animal) were pooled and washed 3 times in CM and
centrifuged for 5 min at 700g at 4°C. Aliquots were taken for differential
and total cell counts, the remaining cells were centrifuged at 700g for 5
min at 4°C and resuspended to 1.2 x 106 McPs/ml. Wright-stained smears
were prepared by cytocentrifugation of cell suspension and cells were
enumerated on a light microscope (Meltzer, 1981b). Cell preparations
consistently contained >90% Mi)s. The viability of cells used in all
experiments was >90% as determined by trypan blue dye exclusion.
3.5. In vitro macrophage-mediated Emethy1-3H1-thymidine
cytotoxicity and cytostasis assays
3.5.1. Effector cells
3.5.1.1. J774 macrophages
Resting J774 Ms have been shown to possess approximately 234 to
355 IL-4R per cell (Lowenthal et al., 1988; Feldman and Finbloom, 1990).
Miner et al. (1983) have shown that polyinosilic-polycytidylic acidactivated J774 Ms were cytolytic to murine B16 melanoma variant
subline B16-F1 (poor lung colonization potential) at 26% lysis, B16-F10
(good lung colonization potential), 12%, and B16-B14b (good lung-, ovary-,
and brain colonization), 15%. Thioglycolate-elicited peritoneal (C57BU6
mice) Ms show similar cytolytic activity as compared with J774 M.s
(24%, 16%, and 17% respectively). J774 Ms were not cytolytic (0%) when
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not activated with polyinosilic-polycytidylic acid.

Interestingly, Tepper

et at. (1989) found that IL-4-producing cells were able to prevent the
growth of C57BI/6 B16-F0 melanoma in their in vivo mixed tumor
transplantation assay.
3.5.1.2. Murine peritoneal macrophages.
It is important that young MI)s be elicited from the circulatory
system since it has been shown that resident peritoneal M+s (or fixed
tissue kil+s in any site) may not be the precursors for activated
tumoricidal cells (Ruco and Meltzer, 1978). Furthermore, resident Ms
respond poorly, if at all, to lymphokine. Ralph et at. (1988) have found that
thioglycolate-elicited Ms (58% cytotoxicity), not stimulated with
lymphokines, are more effective than peptone-elicited Ms (3%
cytotoxicity) in mediating antibody-dependent cellular cytotoxicity.
Therefore peptone-elicited Ms were chosen to show that the tumoricidal
activity obtained, if any, is due to the stimulation of the McPs by IL-4.
3.5.1.3. 14M1.4 bone marrow-derived macrophages
This is a M4) cell line that has just recently been established (Zipori
et al., 1984) and no study using this cell line as an effector for tumor
target cell lysis has been published as yet. However, as mentioned in the
discussion of Chapter 8 (Tan et at., 1992b), IL-4 can induce class I and II
MHC antigen expression in this cell line. Similar upregulation of MHC
antigens was seen in normal bone marrow M4)s but not in other M+ cell
lines, including P388D1, J774.1, PU5.1.8, and WEHI-3, nor in thioglycolateelicited peritoneal A/14)s (Zlotnik et al., 1987; Stuart et at., 1988). 14M1.4
M.s have been demonstrated to possess about 2300 IL-4R per M4)
(Lowenthal et al., 1988).
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3.5.2. [Methyl-31-11-thymidine labelling of target cells
Target tumor cells used for radiolabelling were in exponential
growth phase and about 50% confluent. It is essential to obtain a complete
growth cycle through the initial lag phase, logarithmic or exponential
growth, and finally a plateau at confluence so as to develop a
characteristic growth curve for each cell type against which treated
cultures can be compared. Confluent or overconfluent cultures often do not
incorporate radioactive nuclear labels as well as subconfluent cultures
(Vodinelich and Lennox, 1987), possibly because extracellular signals
through cell receptors indicate to the cells that confluency has been
reached and growth stimulation mediated by intake of extracellular
nutrients (including radioactive label) must be downregulated. In addition,
the spontaneous release of radioactive label from unhealthy cultures will
often be much higher than normal, which makes interpretation of data
difficult. The use of a nuclear label avoids the potential pitfall of a high
spontaneous release of cytoplasmic label (such as 51Cr); use of [methyl3I-1]-thymidine

also does not affect target cell proliferation as has been

reported for [1251] uridine (Meltzer, 1981c).
The procedure for labelling tumor targets with [methy1-3F1]thymidine is detailed in Appendix H. Briefly, subconfluent target cells
were trypsinized, washed, and labelled with [methyl- 31-1]-thymidine for
about 18 h. Unincorporated radiolabel was removed by washing, and tumor
targets adjusted to 1.2 X 105 cells/ml.
3.5.3. The (methyl-31-1J-thymidine cytolytic and cytostatic assays
Cells were activated with murine rIL-4 and tested for tumoricidal
activity towards various tumor target cells (Johnson and Adams, 1986):
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1) H238, a mouse fibroblast tumor cell line; 2) L1210, a mouse
lymphocytic leukemia cell line; 3) PDPaCa, a hamster pancreatic carcinoma
cell line.
NA+s were added to 6 mm 96-well culture plates (Costar, Cambridge,
MA), 1.2 X 105 Ms in 0.1 ml aliquots, and incubated for 2 h. To ensure a
uniform distribution of cells in the wells, the plates are shaken gently
several times at right angles before they are placed in the incubator for
the M+ adherence step (this action helps avoid uneven distribution of cells
around the periphery of the wells due to the vortex created by moving the
cultures from work area to incubator). For peritoneal M+ preparations,
after 2 h incubation at 37°C, non-M., nonadherent cells were removed
(Mosier, 1981) by pipetting 0.2 ml of cold CM into each well, vigorously
swirling the fluid with the pipet, and withdrawing by aspiration. The
monolayers were washed in all directions very vigorously, and the
thoroughness of the resultant wash was routinely and consistently
monitored by microscopy. Since, the washing step is critical to all of
these assays in terms of achieving the desired number and purity of
effectors as well as appropriately bound targets, a minimum of 3 washes
were performed.
Adherent M+s (>95% M+s for peritoneal preparations) that are >90%
viable were cultured with murine r1L-4 (40 U and 200 U in 50 µI volume)
for 4 h. Fifty µI of 1.2 X 105 [methyl-3H]-thymidine prelabelled target
tumor cells/ml or 6 X 103 target tumor cells (giving an effector-to-target
cell ratio of 20:1) were added and incubated at 37°C in 5% CO2. To
determine the duration of the effect of IL-4 cytotoxicity, the released
radioactivity was measured after incubations of 24, 48 and 72 h duration.
Every assay was consistently performed using the experiment design
drawn in Appendix 1.
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Radiolabeled target tumor cells were used as spontaneous release
controls (A1-A3, A7-A9 of Appendix 1). Wells containing control Ms and
radiolabelled target tumor cells were used for background cytotoxicity
controls (A4-A6, A10-Al2 of Appendix 1). Target cells lysed with SDS in
water were used to estimate total maximal release cell-incorporated
counts (Vodinelich and Lennox, 1987). Cytotoxicity (by cytolysis) was
estimated by measurement of radioactivity released into culture fluids at
48 h in triplicate wells and expressed as percent of total SDS counts.
Aliquots of (0.1 ml) culture supernatants were removed and transfered to
scintillation vials containing 0.04 ml of 0.5% SDS, mixed with 10 ml
Biofluor emulsifier cocktail, and counted by liquid scintillation
spectrometry (Parckard Tri-Carb 4530, Downers Grove, IL). The control
wells (i.e., tumor cells alone) were treated with 0.1 ml of 5% SDS, and
0.15 ml of this supernatant was transferred to scintillation vials.
Specific tumor target cellular cytotolysis mediated by 1L-4 activated WI's
and 1L-4 directed cytostasis were calculated as follows:
`)/0 Cytotolysis = cpm (test) - cpm (B) X 100%
cpm (MR-SR)
where SR = spontaneous release,
MR

=

background cytotoxicity, and
maximal release.

% Cytostasis

=

[1-(E-T)/C-T)] X 100%

where T

=

no. of target cells added per well,
no. of target cells in control wells at the
conclusion of the experiment, and
no. of target cells remaining after 1L-4 directed
cytostatic activity.
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3.6. MTT colorimetric cytostasis assay
This colorimetric assay is a modification of the thymidine
incorporation assay and is based on the ability of viable cells to absorb
tetrazolium salts and to cleave the tetrazolium ring by active
mitochondria (Mosmann et al., 1983). The MTT test has previously been
described (Mosmann et al., 1983; Shalaby and Palladino, 1986; Gallagher et
al., 1988). Indicator cells (tumor targets) are added at 2000 cells per •
50 µI per well to standard and test cultures. To determine if IL-4 will
inhibit the growth of tumor cells, various concentrations of IL-4
(4-1667 U) were added in a volume of 50 µI. After 40 h of incubation, MTT
solution (50 lig MTT in 10 µI PBS) was added to each 100 µI cell suspension
contained in each well of the assay, and the plates were further incubated
at 37°C for 4 h. Acid-isopropanol (100 µI of 0.04 N HCL in isopropanol)
was added to all wells and thoroughly mixed to dissolve all dark blue
crystals. After all crystals were dissolved (5 min), the plates were read
on a Dynatech MR 700 Microelisa reader, using a test wavelength of
570 nm, a reference wavelength of 630 nm, and a calibration setting of
1.99. Plates were read within 1 h of the addition of acid-isopropanol, and
optical densities recorded.
3.7. Measurement of IP3
IP3 in M4) suspension was measured using a [311J-labelled IP3
competitive assay kit by Amersham. For a detailed procedure see
Appendix J. Briefly, IL-4 and PLC (positive control, Ilmamura et al., 1990)
was added to Mci) suspensions, and the change in IP3 concentration
measured. IP3 has a tendency to associate with proteins in a chargedependent manner, therefore, extraction procedures using perchloric acid
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were used. Then the extracted 1P3 samples were neutralized by a mixture
of tri-n-octylamine and 1,1,2-trichlorotrifluoroethane and centrifuged to
separate the water-soluble IP3. This water-soluble IP3 was measured by
Amersham's [3F1]-labelled 1P3 competitive assay kit. Plasticware was used
to minimize losses of phosphorylated inositol species.
3.8. Measurement of change in membrane potential
The membrane potential dye Di0C6(3), has been used previously to
load almost any cell (Shapiro, 1988) and in particular PMNs (Lazzari et al.,
1986) and MI's (Valet et al., 1981; Jenssen et al., 1986). Briefly, Di0C6(3)
is dissolved in DMSO and stored in the dark at 25°C as a 1 mM stock
solution. Ten µM working solution Di0C6(3) was made by diluting the stock
solution with analytical grade ethanol 100X. Prior to stimulation with
IL-4, one ml of cell suspension (1 x 106 /m1) in CM was incubated with 5 µI
of 10 OA working Di0C6(3) (final concentration of 50 nM D1006(3)) for 0 to
25 min at 25°C and kinetics determined every minute for dye equilibration.
Since the dye is lipophilic, it tends to be absorbed by the cell membrane.
As a result the cell concentration was held as constant as possible. After
incubation, the cell suspension was introduced into the flow cytometer,
with temperature and flow rate held constant since this is an equilibrium
staining procedure. This dye adsorbs onto the sample tubing within the
flow cytometer, and the adsorption may reach equilibration very slowly
(resulting in a slowly rising baseline of cellular fluorescence). To
minimized this problem, the tubing was pretreated with the dye solution
alone. Kinetics of Di0C6 (3) uptake by MI's were determined by incubating
dye with MI's every min from 0 to 15 min.
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3.8.1. Membrane potential data analysis
After the addition of stimuli, data were collected on 2000 cells at
each 10 s interval for 10 min. The fluorescence distribution for Di0C6(3)
was obtained using a Becton Dickinson FACScan with an argon laser
emitting 4 mW at 488 nm (blue light) to excite the Di0C6(3). Green
fluorescence at 530 nm emission was used for estimation of potentialdependent dye uptake. Unlike the calcium ratio measurement, large cells
which bind more dye will appear more fluorescent, independent of their
membrane potential. Artifacts (debris) and unstained cells (usually below
3%) were excluded by appropriate electronic discriminators. As an
internal standard for fluorescence intensity, FITC-labelled monosized
latex particles of 1.83 gm diameter (Polysciences, Warrington, PA) were
measured before and after each series of experiments. As with indo-1
calcium analysis, the resulting fluorescence profiles, were analyzed and
displayed as histograms and as ratio of mean fluorescence vs. time.
3.8.2. Controls
Controls include an untreated cell sample (in RPM! 1640, a high-Na,
low K+ [5 x 10-3 M] medium), a sample of cells hyperpolarized by addition
of 50 gl of 0.5 mM (5 mg in 8.9 ml absolute ethanol, with a final
concentration of 25 I.LM) valinomycin, and another sample depolarized by
addition of 25 gl of 2 mM (100 mg in 26.6 ml ethanol, with a final
concentration of 50 gM) gramicidin. In this way, the cells were
established to have a nonzero potential difference across their cell
membranes, and the indicator dye used will cause the cells to respond to
potential changes in either direction from the control value. Valinomycin,
which is lipophilic, forms a complex with K+ ions and can thus readily
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transport them across cell membranes. Addition of valinomycin thus
effectively increases the cellular potassium permeability to the point at
which membrane potential is determined almost entirely by the
transmembrane [K] gradient. If [K10 is low, valinomycin addition
hyperpolarizes the cells; if [K]0 is high, valinomycin addition depolarizes
the cells, and if [K10.[KI, valinomycin addition does not change membrane
potential. To ensure that the ethanol (‘. 50 µI) used to dissolve
valinomycin and gramicidin had no effect on the change in membrane
potential of Ms, 50 1.1.1 ethanol was added to a cell suspension containing
equilibrated dye, and the change in membrane potential was measured.
3.8.3. Limitations and possible problems
The cyanine dyes are recognized to have a variety of toxic and
inhibitory effects, as well as certain limitations inherent in the use of
cationic probes (see review by Chused et al., 1986). These dyes act to
uncouple oxidative phosphorylation, deplete cellular ATP, block Ca2+dependent K+ conductances, and cause depolarization of the resting
membrane potential of lymphocytes and PMNs. These toxicities can be
reduced by use of lower dye concentrations. In addition, mitochondrial
potentials are highly negative and cyanine dye association with
mitochondria can be a substantial component of the total fluorescence
signal. A high ratio of dye/cell has been reported to decrease the
partitioning of cyanine dye in mitochondria (Chused et al., 1986).
These problems can be circumvented by using low dye concentrations,
(‘. 50 nM) and assaying on the flow cytometer (Shapiro, 1981).
Finally, the dye concentration in suspensions of cells in a cyanine
dye may be poorly buffered, in that the major fraction of dye may be cellassociated. Extrusion of dye from a subpopulation of cells may increase
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the available extracellular dye, which then may be taken up by another cell
population (independent of changes in membrane potential) merely due to
changes in concentration of dye in the medium. Thus, the cyanine dyes,
under the best conditions, will not yield absolute values of membrane
potential to the nearest millivolt (Shapiro, 1988).
3.9. Measurement of change in intracellular calcium.
3.9.1. Flow cytometry assay with indo-1
A primary advantage of flow cytometry is that by analysis of large
numbers of individual cells, heterogeneity in cellular characteristics may
be observed that would not be apparent in a bulk spectrofluorimetric
assay. Increased sensitivity to small changes may also be possible by
detection of alterations in a small proportion of cells, which might
otherwise be masked by the unresponsive population. Rabinovitch et al.
(1986) have demonstrated that the flow cytometric assay• with indo-1 can
detect less than a 0.3% subpopulation of cells responding to a stimulus of
[Ca24 ]1 flux.
Thioglycolate-elicited murine peritoneal McPs and J774 McPs in
suspension and monolayer culture have been demonstrated to possess
resting [Ca2 ]; of 110-140 nM and 85-120 nM, respectively, as measured by
quin2 and fura-2 fluorescence spectrophotometry (DiVirgilio et al.,
1988a). For both Mcl) populations, the resting [Ca21; was consistently 25%
lower in monolayer cultures than with suspension cultures. In addition,
the increase in [Ca2+] (when activated with IgG) is reproducible in
suspension cultures but not in monolayer cultures. Thus, Ms for these
experiments utilized Mctss from a suspension culture. It was also noted by
DiVirgilio et al. (1988a) that the increase in [Ca2 ] caused by ligation of
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Fc receptors was mainly due to release of Ca2+ from intracellular stores in
J774 as opposed to influx of extracellular Ca2+ in thioglycolate-elicited
M.s, probably due to differences in M4) populations in response to the same
stimuli. In the presence of probenecid, which prevents the leakage of
indo-1 (especially known to occur in J774 M.$) Greenberg et al. (1988)
demonstrated in a spectrofluorimetric assay that the [Ca21; of J774 MPs
was about 160 nM (range of 130-210 nM).
3.9.2. Limitations and possible problems
1) It has been suggested that indo-1AM may be incompletely
deesterified within some cell types (e.g. endothelial cells; Luckhoff,
1986). Since the ester has little fluorescence spectral dependence upon
Ca2+, the presence of this dye form could lead to falsely decreased
estimates of [Ca21. However, results of calibration experiments can be
used to monitor for this possibility. 2) It is usually observed that not all
cells, even of a specific immunophenotypic subset, respond to a particular
signal, and of those that do, the values of [Ca2+1 are quite heterogeneous.
Some of this heterogeneity is due to differences in cell subsets. It is not
known to what extent the residual heterogeneity in [Ca2 ] represents the
effect of oscillations of [Ca24-]; within individual cells as a function of
time (Rasmussen, 1989; Berridge and Moreton, 1991). Since flow
cytometric analysis does not allow for repeated examination of a cell
sample, other techniques (e.g. digital microscopy; Wilson et al., 1987)
must be used to address this question. 3) lndo-1, fura-2 and other organic
anion fluorescent dyes that are sequestered in the cytoplasmic vacuoles or
endosomes of Mots, are efficiently secreted from the cells (Greenberg et
al., 1988; DiVirgilio et al., 1988b; Lipman et al., 1990). The secretion of
these dyes into the extracellular medium is thought to be mediated through
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organic anion transporters and can be inhibited by probenecid. The 14M1.4
Ws appear not to possess efficient organic anion transporters for indo-1
because fluorescence from these McPs, as indicated by flow cytometric
measurements, did not decrease after a period of 10 min (Tan et al.,
unpublished observation).
3.9.3. Reagents
The choice of medium in which the cell sample is suspended for
analysis is dictated primarily by the metabolic requirements of the cells,
subject only to the presence of mM concentrations of calcium (to enable
calcium agonist-stimulated calcium influx) and reasonable buffering.
Although the new generation of Ca2+ indicator dyes are not highly sensitive
to small fluctuations of pH over the physiologic range, bicarbonate
buffered solutions can impart uncontrolled pH shifts. To circumvent the
above problems, RPM! 1640 with 25 mM N-2-hydroxyethylpiperazine-N'-2ethanesulfonic acid (HEPES) and 0.42 mM total calcium concentration are
used (see Table 1). The use of phenol red as a pH indicator does not impair

Table I
Calcium concentration and pH of RPM! 1640

RPMI 1640 CM

RPM! 1640

pH*

7.370

7.479

Ionized [Ca2+],* :

390 µM

250 µM

Total [Ca2+]**
:

600 µM

420 µM

Measured with the *Ciba-Corning 288 Blood Gas System and the **Kodak
EktaChem 700 Analyzer.

65
the detection of indo-1 fluorescence signals (Shapiro, 1988).
3.9.4. Instrumental technique
Since the indo-1 excitation maximum is within 330-350 nm,
depending upon the presence of calcium (June et al., 1987), the indo-1
fluorescence was excited by UV light (150-200 mW) with a fluorescenceactivated cell sorter (FAGS) 440, 5W argon laser that can be tuned to a
range of 351-365 nm, very close to the excitation maximum (Tsien,
1989a). The free dye maximum emission is at 482-495 nm (blue) while
the Ca2+-bound dye maximum emission is at 398-405 nm (violet)
(Grynkiewicz et al., 1985). The emitted light was split with a 440 nm
dichroic splitter. Free indo-1 emission was measured at 495 nm with a
. -1 emission at 405 nm with a
20 nm bandpass filter, and Ca2+-bound indo
35 nm bandpass filter. The ratio of FUV405/FUV495 is the measure of [Ca2+].
3.9.5. Controls
A negative control (very low [Ca21) was created by incubating indo1AM loaded cells in 15 mM EGTA (30 p.I 0.5M stock solution, made from
0.5706 g/3 ml Ca2+-free PBS, to 1 ml cell suspension) containing 0.0016%
(w/w) saponin (20 µ.1 0.08% stock solution, made from 0.0008 g/g Ca24-free PBS, to 1 ml cell suspension) for 1 h at 37°C in 5% CO2 (Griffioen et
al. 1989). This concentration of EGTA and saponin was sufficiently low to
allow 90% of the McPs to remain viable for at least 2 hours after
preparation. A positive control (very high [Ca21) was generated by adding
5 µM ionomycin (5 µI of 1 mM stock solution prepared from 1 mg
ionomycin/1.4 ml DMSO) to indo-1 loaded cells. lonomycin-treated cells
reach near-saturating levels of [Ca2+] (Rabinovitch et al., 1986).
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3.9.6. Loading of indo-1 (Rabinovitch et al., 1986; Lazzari et al.,
1986; Baud et al., 1987; June and Rabinovitch, 1988; Lopez et al., 1989;
Bernardo et al., 1990)
One mM (1 mg in 0.992 ml anhydrous DMSO) indo-1AM stock solution
was aliquoted to ten 100 µI vials and stored dessicated in the dark at
-20°C.

Three microliters of indo-1 were removed from an aliquot and

diluted with 1 ml CM. Ml's were washed twice and resuspended to 2 x 107
cells/ml in medium (prewarmed to 37°C from here onward). Cells (1 ml)
were loaded by incubation with 1 ml of indo-1AM solution (3 µM) to yield a
final concentration of 1.5 µM. After the cells were incubated for 15 min at
37°C in the dark, the cell suspension was diluted 7-fold (to reduce toxicity
of dye to cells) with 11 ml medium containing 1 ml 30 mM probenecid
(8.56 mg probenecid/ml PBS, a final concentration of 2.5 mM), and
incubated an additional 15 min for a total of 30 min at 37°C (to allow
complete intracellular hydrolysis of indo-1AM to indo-1 free acid,
Greenberg et al., 1988)1 . Cells were then washed twice at 4°C to remove
unincorporated indo-1AM, preferably to 10 nM or lower, and resuspended in
fresh medium at 2.5 x 106/ml. Cells were kept in the dark to prevent any
significant leakage of the dye (the efficiency of cellular dye uptake and
trapping is about 20%). Fifteen minutes before analysis, indo-1-loaded
cells were diluted to 1 x 106/m1 with CM and equilibrated at 37°C in 5%
CO2. The effects of stimulation on indo-1-loaded Ml's were analyzed by

1 It was found later, that probenecid was not needed as 14M1.4 Os do not appear to possess

anion transporters that secrete indo-1 efficiently. Indo-1 loading appears to be complete by
the end of 30 min incubation as determined by observing no change in fluorescence assessed
by flow cytometric analysis. It has been demonstrated that loading is more rapid in monocytes
than in lymphocytes due to variation in intracellular esterase activity (June and Rabinovitch,
1988). The lower limit of intracellular concentrations of indo-1 is determined by the
sensitivity of fluorescence detection of the flow cytometer and the upper limit is determined
by avoidance of buffering of [Ca21 by the presence of the calcium chelating dye itself.
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flow cytometry at a rate of 400 cells/s at 37°C 2.

In order to obtain values

for resting cells, each sample was run for 60 s before addition of a
stimulant (50 µI IL-4 to give a final concentration of 200 U/2 x 105 AO's,
or 50 µI ionomycin to give a final concentration of 5 or 50 µM). After
addition of the stimulants, data were recorded for a period of 10 min. The
flow of cells was halted at this time, and the sample line was flushed to
remove stimulated cells before analysis was resumed. Physiologic
variation has been documented to be <10% (Rabinovitch et al., 1986) and
autofluorescence (fluorescence of unloaded and dead cells) about 5-10%
(Ransom et al., 1987).
3.9.7. Determination of source of increased [Ca2+Ji
Of primary interest is the source of increased [Ca21. Is it from the
release of intracellular storage or from an extracellular influx? The
release Ca2+ from intracellular stores, independent of extracellular Ca2+
influx, can be determined by adding BAPTA-AM, a specific intracellular
calcium chelator (Gelfand et al., 1987). Likewise, the increase in pa21;
from an extracellular influx can be determined by adding 5 mM EGTA (final
concentration) to the cell suspension to abolish the usual extracellularto-intracellular gradient. This reduces the extracellular ionized [Ca2+J
nearly 100-fold, to about 15 nM (June et al. 1986) in the presence of RPMI
1640 medium containing 10% heat-inactivated serum and a total calcium
concentration of 0.600 µM and ionized calcium of 0.39 µM.

2 Regulation of the temperature of the cell sample is essential, as transmembrane signaling and

calcium mobilization are temperature-dependent and active processes. If cells are allowed to
cool before they flow past the laser beam, [Ca21i will often decline, so that either the sample
input tubing was warmed, or narrow-gauge tubing and high flow rates (e.g., z 50 µI
sample/min) was used to keep transit times from the sample uptake port to the flow cell
chamber minimized.
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3.9.8. Calcium data analysis
Five parameters were recorded: volume (forward angle scatter), free
dye by blue fluorescence (fluorescence 1), bound dye by violet fluorescence
(fluorescence 2), granularity (side scatter), and time. The blue and violet
fluorescence were displayed on a linear scale. The photomultiplier setting
for fluorescence was chosen so that the mean ratio for resting cells was
between channels 80 and 160 (full scale 1024). Data analysis was
performed using the CICERO calcium analysis software (Cytomation,
Englewood, CO). Data from indo-1 analyses were stored in 'list mode' for
later analysis in which the y-axis represented the bound (violet, 405 nm)
to free (blue, 495 nm) indo-1 fluorescence ratio and the x-axis
represented elapsed time. The isometric displays were analyzed by CICERO
and the mean of the indo-1 violet (405 nm) to blue (495 nm) fluorescence
ratio or the percentage of responding cells against time were calculated.
The percentage of responding cells was calculated as the proportion of
cells having an indo-1 ratio of more than two standard deviations above
the mean value for control cells. There were 120 data points on the x-axis
(time) on plots of either mean indo-1 ratio or the percentage of responding
cells. Each of these data points represents the average value of
approximately 2000 cells analyzed during the 5 s that constitute each data
point.
3.10.

Statistical analysis
Where appropriate, data were expressed as the mean ±. standard error

of the mean (SEM). In experiments where only two groups were compared,
the significance of differences were assessed using a two-tailed Student t
test (Lutz, 1986) in the Macintosh SE StatWorkirm program. For multiple
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group comparisons, the significance of overall difference between the
group means was determined by one-way analysis of variance (ANOVA,
Lutz, 1986); and between individual groups by Tukey's test for honestly
significant difference. Significance between experiments and controls
were defined as probability (p) < 0.05. Statgraphics software version 3.0
(STSC, Inc., Rockville, MD) was used for analyses.
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FURTHER EVIDENCE OF MUR1NE RECOMBINANT 1L-4 SPECIES
SPECIFICITY AS MEASURED BY CHEMILUMINESCENT OXIDATIVE
BURST IN MACROPHAGES

4.1. ABSTRACT
We provide further evidence that murine 1L-4 is a highly species
specific lymphokine that will not cross even the narrow phylogenetic
barrier to hamster and perhaps only partially to rat. The release of
reactive oxygen intermediates in hamster peritoneal Ms incubated with
IL-4 (over a range of 4-1000 U/ml) for 24, 48, and 72 h were similar to
that of non-stimulated controls. However, murine IL-4 induced a small but
significant dose-dependent, monoclonal anti-1L-4 irreversiblel
stimulation of reactive oxygen intermediates in rat peritoneal Ms.
4.2. INTRODUCTION
IL-4, in the presence of macrophages (M.$), has previously been
demonstrated to be tumoricidal in vitro and in vivo, possibly through M.
activation (Crawford et al., 1987; Tepper et al., 1989; Golumbek et al.,
1991; Redmond et al., 1991; Wong et al., 1992; Lotze, 1992a, b). In mid
1987, it was not known whether murine IL-4 is species specific or that it
will cross narrow phylogenetic barriers and has any biological activity on
hamster M.s. The initial goal of this research proposal2 was to activate
hamster M.s with IL-4 to study M. tumoricidal activity against hamster
pancreatic adenocarcinoma in vivo.

Therefore, to determine if hamster

1 Although non-specific stimulation by IL-4 cannot be ruled out.

2 lmmunobiology of Cancer Fund, Loma Linda University, School of Medicine.
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cells will response to murine IL-4, hamster Ms were cocultured with the
cytokine and the IL-4-enhanced chemiluminescent oxidative burst was
measured. In addition, to further delineate the species specificity of
murine IL-4, rat Ms were also exposed to the cytokine.
4.3. MATERIALS AND METHODS
Chemiluminescence assays were performed in an automated
luminometer (Picolite model 6500, Packard Instrument Co., Downers
Grove, IL) interfaced with a PC-compatible computer as previously
described (Tosk et al., 1989; Tan et al., 1991d (Chapter 5), 1992b (Chapter
8)). Peritoneal Mi)s were obtained from Golden Syrian hamsters and
Sprague Dawley rats which had received 3 ml sterile 3% proteose peptone
i.p. 3 days previously (Section 3.4.3. of Materials and Methods in this
thesis). Ms were incubated with various concentrations of IL-4 (4-1000
U), incubated for 24, 48, and 72 h and assayed for chemiluminescence. LPS
was used as a positive control (Pabst et al., 1982; Tosk et al., 1989).
4.4. RESULTS
4.4.1. Effect of murine 1L-4 on hamster peritoneal macrophages
To test if murine IL-4 has any activity on hamster cells, a M4)
activation assay was used to measure the amount of chemiluminescence
released by M. production of reactive oxygen intermediates. M4)s from
peritoneal exudates of golden Syrian hamsters were induced with proteose
peptone and treated with various concentrations of IL-4 (0-1000 U) for
24, 48, and 72h. As shown in Fig. 1, there was no effect (p > 0.05) of IL-4
on the oxidative burst of hamster peritoneal Ms when incubated with all
concentrations of IL-4 for 24 h (Fig. 1a), 48 h (Fig. 1 b) and 72 h (Fig. 1c).
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LPS at 100 ng/ml (with or without 1L-4) was used as a positive control to
induce an enhanced chemiluminescence (Pabst et al., 1982; Tosk et al.,
1989). The chemiluminescence of control M.s triggered with zymosan
alone (without IL-4) was from 106-107 integrated photon emission.
4.4.2. Effect of murine IL-4 on rat peritoneal macrophages
To test if murine IL-4 has activity on rat cells, a chemiluminescence
assay was conducted on proteose peptone-elicited peritoneal AMPs from
Sprague Dawley rats after incubation with various concentrations of IL-4
(0-1000 U) for 24, 48, and 72h. In contrast to the effect of murine
1L-4 on hamster Ms, murine IL-4 induced a small but significant
(p < 0.05) dose-dependent stimulation of reactive oxygen intermediates in
rat peritoneal McPs (Fig. 2). After 24 h and 48 h incubation with IL-4, Ms
released significant (p < 0.05) amounts of reactive oxygen intermediates
at 40-1000 U 1L-4 (Fig. 2a, b). With longer IL-4 incubation time (72 h),
M4)s showed an enhanced chemiluminescence only with 1000 U IL-4 (Fig.
2c). LPS (100 ng/ml) was used as a positive control (Gardner et al., 1992).
However, with 72 h I1-4 incubation time, LPS no longer enhanced the
chemiluminescence due to the toxicity of LPS and resulting decreased cell
viability.
To test if the effect of murine IL-4 on rat M4os was wholly dependent
on the cytokine, anti-IL-4 mAb was used to block cytokine activity. The
stimulation of reactive oxygen intermediate production by IL-4 action on
the MSs was anti-IL-4 irreversible (Fig. 3).
4.5. DISCUSSION
Pancreatic cancer is the fourth most common cause of cancer death
in the United States and is recognized as the most lethal of all cancers
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(Silverberg and Lubera, 1987). Even with current technological treatment
modalities, we found, in a retrospective chart review, a low overall
median survival of approximately 3.9 months (Tan et al., 1986, 1987a, b).
The goal of this early research was to develop in vitro and in vivo hamster
models whereby protocols applicable to the treatment of epithelial
cancers, e.g. pancreatic adenocarcinoma, can be tested. The Syrian Golden
hamster pancreatic cancer model was used since this adenocarcinoma,
induced by the transplantable PC-1 tumor cell line, had been demonstrated
to share morphological, biological and immunological characteristics with
the human disease (Pour et al., 1981; Egami et al., 1989). To initiate this
study, we performed the chemiluminescent oxidative burst assay to
determine if IL-4-stimulated hamster peritoneal M(Ps are activated to
release free reactive oxygen intermediates (Tan et al., 1991b). The
activation of Ms and their release of free reactive oxygen intermediates,
including 02- and H202, have been correlated with an enhanced ability to
kill bacteria (Gabay, 1989), parasites (Wirth et al., 1989), and tumor cells
(Wiltrout, 1990).
In mid 1987, it was not known whether murine 1L-4 is species
specific or that it will cross narrow phylogenetic barriers and has any
biological activity on hamster M44s. However, it was found later that there
is no species cross reactivity between murine IL-4 and human cells, and
human IL-4 and murine cells (Mosmann et al., 1987; Ohara and Paul, 1987)
although both human rIL-4 and murine rIL-4 cDNA clones share 50%
homology at the amino acid level as inferred from nucleotide sequence
(Yokota et al., 1988) and exhibit similar activities in many instances.
Later, Leitenberg and Feldbush (1988) found that murine IL-4 will not
induce class II MHC antigen expression on rat B cells. Our results (Tan et
al., 1991b) extends this observation of murine rIL-4 as a highly species
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specific cytokine that will not cross even the narrow phylogenetic barrier
to hamster and perhaps only partially to rat. The species specificity of
the ten currently available interleukins, as standardized by the WHO-IUIS
Nomenclature Subcommittee on Interleukin Designation (1992), is
reviewed in Appendix 0.
Interestingly, LPS suppressed the oxidative burst of 1L-4-stimulated
rat peritoneal Ms when incubated for 48 h. This was also seen when
murine 14M1.4 bone marrow-derived Mots were stimulated with LPS for
incubation times greater than the optimal period for chemiluminescence
(Chapter 8, Tan et al., 1992b). It appeared that LPS when incubated for a
longer period of time was toxic to these M.s, as observed by the slight
decrease in viability. It has been demonstrated that LPS will enhance the
oxidative burst of J774 McPs (Tosk et at., 1989) and kill tumor cells in
vitro, but not of bone marrow-derived McOs (Tan et at., 1992b; Keller et al.,
1992). Another finding was that the stimulation of reactive oxygen
intermediates by IL-4 on rat peritoneal Mctos was anti-IL-4 irreversible
indicating that non-specific stimulation of the Ms by 1L-4 cannot be ruled
out. Indeed, one can see that non-specific stimulation does occur (Fig. 3)
probably at the Fey receptor (Johnston et al., 1976) of rat McPs through the
binding of anti-IL-4, an IgG molecule.
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5.1. ABSTRACT
We evaluated the effects of murine recombinant
interleukin-4 (rIL-4) on murine peritoneal macrophages. We
showed a marked, dose-dependent stimulation of respiratory
oxidative burst by IL-4 in peptone-elicited murine peritoneal
macrophages. This effect was abolished by a neutralizing
monoclonal antibody (mAb) to r1L-4 confirming that the
enhanced chemiluminescence was due to 1L-4. In contrast, rIL-4
depressed the respiratory oxidative burst of a transformed
murine macrophage cell line, J774, in a dose-dependent mAbreversible manner.
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5.2. INTRODUCTION
Interleukin-4 (IL-4) was originally described as a murine B-cell
growth factor [10] and has subsequently been shown to have pleiotropic
effects on multiple hematological [reviewed in 14, 191 and
nonhematological [15] cellular lineages. The effects of IL-4 on
macrophages include the induction of class I and class II antigen
expression as well as enhancement of their tumoricidal activity in vitro.
This has led to the description of 1L-4 as a macrophage-activating factor
[3,21]. Recently, macrophages have been implicated in IL-4-mediated
antitumor activity in vivo [22].
In this study, we have evaluated the macrophage-activating
properties of murine IL-4 on the formation of reactive oxygen
intermediates (ROI) measured by monitoring zymosan-triggered
chemiluminescent oxidative burst. We report here that IL-4 induced a
dose-dependent enhancement of chemiluminescence (CL) in murine
peritoneal macrophages triggered with zymosan. In contrast, IL-4
inhibited the zymosan-triggered CL in the J774 murine macrophage cell
line.

5.3. MATERIALS AND METHODS
Animals
Balb/c mice 8-12 weeks old, purchased from Charles River
Laboratories, (Wilmington, MA) were screened and found to be negative for
bacterial pathogens, parasites, and subclinical viral infections.
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IL-4
Murine r1L-4 was kindly provided by Dr. Steven Gillis (Immunex Corp.
Seattle, WA). This protein had a specific activity of 108 U/mg, 1 U being
defined as half-maximal stimulation in a standard antiimmunoglobulin
comitogenesis assay [8].
Anti-IL-4 Monoclonal Antibody (mAb)
Anti-1L-4 (TexStar Monoclonals, Dallas, TX) is an IgGi lc affinitypurified mAb from 116115E3 (a high producer subclone of 11611 [18])
hybridoma culture supernatant. This anti-IL-4 mAb blocked the biological
activity of IL-4 as measured in HT-2 proliferation, B-cell differentiation
factor-y, and B-cell growth factor-lalg-costimulation assays.
Cell Preparations
The macrophage cell line J774A.1 was obtained from the American
Type Culture Collection (Rockville, MD). J774 macrophages were grown in
DMEM (GIBCO, Grand Island, NY) supplemented with 10% heat inactivated
defined fetal bovine serum (FBS) (Hyclone Laboratories, Inc., Logan, UT),
penicillin (50 U/m1) and streptomycin (100 µg/m1), hereafter known as
complete media (CM). Peritoneal macrophages from Balb/c mice treated 3
days previously with 3 ml sterile 3% proteose peptone (D1FC0, Detroit, MI)
in PBS were collected after intraperitoneal injection of CM containing
10 Wm! heparin [3]. Macrophages were withdrawn through the anterior
abdominal wall by peritoneal lavage. Harvested macrophages were washed
three times in CM for 5 min at 400g at 4°C. The pellet was resuspended in
CM and a sample taken for differential and total cell counts. The
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remainder was centrifuged at 250g for 10 min at 4°C and resuspended to
1.3 x 106 macrophagesliml. Wright-stained cell smears were prepared by
cytocentrifugation and counted on a light microscope. These smears
showed >90% macrophlages. The viability of cells used in all experiments
was >90% as determined by Trypan blue dye exclusion.
CL Assays
CL assays were performed at 37°C in an automated luminometer
(Picolite model 6500, Packard Instrument Co., Downers Grove, IL)
interfaced with a PC-compatible computer [23]. Experiments were
performed in triplicate and repeated at least three times. Peritoneal
macrophages and J77.0nacrophages were made up in DME/F-12 medium
without indicator (Sigma) supplemented with 10% FBS and antibiotics.
These suspensions were added to 55 X 12 mm plastic luminometry tubes
(Los Alamos Diagnostic, Los Alamos, NM). Each tube contained 2 x 105
cells in a volume of one ml. Fifty microliters of IL-4 or media were added
to cell suspensions and incubated in 5% CO2 atmosphere at 37°C for 18-24
hr prior to the assay t4 allow for adherence of cells to the bottom of the
luminometry tubes. After incubation the supernatant was removed and
discarded. The viability of macrophages was consistently >90% for all
incubation times reportd in both the J774 and peritoneal macrophages.
The CL assay was initiated by the automated addition of 200 µI of a
zymosan A suspension. The zymosan A suspension was prepared according
to a modified method reported previously [2], and contained per 100 ml
complete veronal buffer pH 7.3, 250 mg zymosan A, 200 µI of a 20 mM
solution of luminol in DMSO, and 100 µg globulin-free bovine serum
albumin. Zymosan A suspensions were prepared in advance and stored
frozen at -70°C in 10 ml aliquots. The photon emission from samples was
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counted every 8 min for 72 min. The area under each of the curves
representing light emission over time was reported as integrated photon
emission.
Statistical Analysis
Where appropriate, data were expressed as the mean ± SEM. For
multiple group comparisons, the significance of overall difference
between the group means was determined by one-way analysis of variance
(ANOVA); and between individual groups by Tukey's test for honestly
significant difference (HSD). Significance between experiments and
controls were defined as P < 0.05. Statgraphics software version 3.0
(STSC, Inc., Rockville, MD) was used.

5.4. RESULTS
Murine Peritoneal Macrophages
The production of ROI by activated macrophages is an important
mechanism of cytotoxicity. Therefore, we evaluated the production of ROI
by activating murine macrophages with IL-4. Macrophages from peritoneal
exudates induced by proteose peptone were treated with various
concentrations of IL-4 (4-1000 U/m1) for 24 hr (Fig. 1). The CL of these
macrophages triggered with zymosan was on the order of 107-108,
integrated over a period of 72 min. Macrophages treated with 5 200 U/ml
of IL-4 showed a dose-dependent enhancement of oxidative burst as
measured by CL emission (P < 0.05). In the presence of 200 U/ml of IL-4,
macrophages consistently showed an optimal ROI producing capacity twice
that of control macrophages. The enhancement of ROI production was also
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seen at 48, 18, 12 and even 6 hr incubation times [This data is reproduced
in Appendix M]. Dosages 200 U/m1 of 1L-4 were associated with a
plateau in activity.
Monoclonal anti-IL-4 had no effect on macrophage CL (Fig. 2). We
found that 16 µg/m1 of 1L-4 mAb completely abolished the CL oxidative
burst of peritoneal macrophages activated with 200 U/m1 1L-4.
J774A.1 Macrophages
The effect of 1L-4 on the oxidative burst of J774 cells is illustrated
in Figure 3. In the presence of 200 U/ml of 1L-4, ROI production was
suppressed in J774 macrophages at 48 hr but no effect was evident at
12 hr incubation (data not shown). A dose-related suppression of CL
emission is evident. This effect was abolished by monoclonal anti-IL-4
(Fig. 4). At a dosage of 8 µg/m1 the mAb entirely abrogated the inhibitory
activity of IL-4 (100 U/ml). Figure 4 also shows that the mAb had no
effect of its own on the oxidative burst of J774 macrophages.

5.6. DISCUSSION
In the present study, we demonstrated that muriine rIL-4 enhances CL
during oxidative burst in murine peritoneal macrophages in a dosedependent fashion. On the other hand, the CL exhibited during oxidative
burst of the J774 macrophage cell line was significantly suppressed by
IL-4. The activation of macrophages and their release of free ROI,
including 02- and H202, have been correlated with an enhanced ability to
kill bacteria [reviewed in 61, parasites [25], and tumor cells [reviewed in
24]. This is in contrast to results obtained with human mononuclear
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